https://www.pharmaceutical-business-review.com/news/takeda-immunogen-sign-potential-440m-drug-development-deal-240315-4538591/ 2015-03-24T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/kamadas-gvhd-treatment-aat-gets-european-orphan-drug-status-240315-4538639/ 2015-03-24T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/genvec-therabiologics-to-develop-new-cancer-therapeutics-240315-4538756/ 2015-03-24T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-inks-distribution-deal-with-cipher-for-cf101-in-canada-240315-4538798/ 2015-03-24T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-reports-phase-ii-trial-results-of-vx-661-in-combination-with-ivacaftor-in-cystic-fibrosis-240315-4539125/ 2015-03-24T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-phase-iii-keynote-006-trial-of-melanoma-drug-keytruda-meets-co-primary-endpoints-250315-4539450/ 2015-03-25T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/biohaven-enters-into-license-deal-for-catalents-zydis-odt-technology-250315-4539744/ 2015-03-25T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/regene-acquires-new-laboratory-facilities-in-us-250315-4539778/ 2015-03-25T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmax-launches-hlc-baby-b-and-hlc-baby-f-probiotic-supplements-250315-4539807/ 2015-03-25T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ngm-reports-positive-phase-ii-trial-results-of-ngm282-in-pbc-patients-250315-4539925/ 2015-03-25T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-to-advance-development-of-next-generation-anthrax-vaccine-nuthrax-250315-4539968/ 2015-03-25T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-gets-fda-orphan-drug-status-for-ag-348-to-treat-pyruvate-kinase-deficiency-250315-4540001/ 2015-03-25T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-harvard-stem-cell-institute-enter-five-year-diabetes-research-collaboration-260315-4540337/ 2015-03-26T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/marinus-gets-fda-orphan-drug-status-for-ganaxolone-to-treat-pcdh19-female-epilepsy-260315-4540685/ 2015-03-26T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/regulus-rg-012-gets-orphan-medicinal-product-designation-in-europe-to-treat-alport-syndrome-260315-4540713/ 2015-03-26T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-cymabays-mbx-8025-to-treat-hofh-260315-4540754/ 2015-03-26T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sanofi-pasteurs-quadracel-vaccine-for-children-four-to-six-years-of-age-260315-4540805/ 2015-03-26T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/teikoku-gets-fda-acknowledgment-of-receipt-for-docetaxel-injection-260315-4540907/ 2015-03-26T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/signum-out-licenses-sig990-to-dermata-to-develop-new-topical-treatment-for-rosacea-260315-4540887/ 2015-03-26T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithklines-copd-treatment-encruse-ellipta-gets-japanese-approval-270315-4541386/ 2015-03-26T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-introduces-hemophilia-therapy-novoeight-in-us-270315-4541749/ 2015-03-27T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-american-diabetes-association-partner-to-educate-adults-with-diabetes-270315-4541848/ 2015-03-27T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-secures-approval-in-japan-for-sovaldi-to-treat-genotype-2-chronic-hcv-270315-4541946/ 2015-03-27T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/takedas-nda-of-zafatek-tablets-gets-approval-in-japan-to-treat-type-2-diabetes-270315-4541995/ 2015-03-27T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-begins-dosing-in-phase-ib-relday-multi-dose-clinical-trial-to-treat-schizophrenia-270315-4542065/ 2015-03-27T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-gets-japanese-approval-for-gadovist-injection-270315-4541913/ 2015-03-27T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/eisais-thyroid-cancer-drug-lenvima-gets-positive-opinion-from-emas-chmp-300315-4542398/ 2015-03-29T23:23:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-uk-department-of-health-sign-meningitis-b-vaccine-deal-300315-4542647/ 2015-03-30T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/adamis-gets-fda-complete-response-letter-for-epinephrine-pre-filled-syringe-nda-300315-4542713/ 2015-03-30T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/china-fda-accepts-for-review-wuxi-medimmunes-ind-for-monoclonal-antibody-300315-4542757/ 2015-03-30T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-biogen-and-abbvies-maa-for-zinbryta-to-treat-multiple-sclerosis-300315-4542798/ 2015-03-30T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/rxi-mirimmune-to-develop-cancer-immunotherapies-using-sd-rxrna-technology-300315-4542670/ 2015-03-30T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/pledpharma-reports-positive-top-line-phase-iib-trial-results-of-colorectal-cancer-drug-pledox-300315-4542839/ 2015-03-30T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-boehringer-and-lillys-combination-therapy-for-type-2-diabetes-310315-4543477/ 2015-03-31T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-strengthens-cns-franchise-with-35bn-acquisition-of-auspex-pharma-310315-4543642/ 2015-03-31T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-completes-acquisition-of-australias-pharmapak-310315-4543522/ 2015-03-31T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-to-buy-hyperion-therapeutics-for-11bn-310315-4543767/ 2015-03-31T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/intrexon-merck-ink-deal-to-develop-commercialize-car-t-cancer-therapy-310315-4543902/ 2015-03-31T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-aduro-biotech-partner-to-accelerate-cancer-immunotherapy-efforts-310315-4543994/ 2015-03-31T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/casi-gets-cfda-approval-to-conduct-phase-ii-trial-of-enmd-2076-to-treat-occc-310315-4543807/ 2015-03-31T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-syndax-to-evaluate-keytruda-cancer-combination-therapy-010415-4544429/ 2015-04-01T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-acquires-belgian-otc-firm-omega-pharma-for-eur38bn-010415-4544530/ 2015-04-01T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-expands-collaboration-with-mit-and-harvard-for-new-cardiovascular-therapies-010415-4544494/ 2015-04-01T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/amneal-to-buy-actavis-generic-pharmaceutical-business-in-australia-010415-4544663/ 2015-04-01T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-amlodipine-and-valsartan-tablets-in-us-to-treat-hypertension-010415-4544711/ 2015-04-01T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-gets-35m-contract-for-new-ebola-treatment-010415-4544823/ 2015-04-01T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharmaceuticals-introduces-propafenone-tablets-to-treat-several-arrhythmias-010415-4544850/ 2015-04-01T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-completes-acquisition-of-salix-pharmaceuticals-for-173-per-share-020415-4545598/ 2015-04-02T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-agrees-to-buy-select-ucb-brands-in-india-for-128m-020415-4545808/ 2015-04-02T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-ideras-imo-8400-to-treat-diffuse-large-b-cell-lymphoma-020415-4545862/ 2015-04-02T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-plaque-psoriasis-drug-humira-gets-marketing-approval-in-europe-020415-4545840/ 2015-04-02T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-launches-natpara-for-injection-in-us-for-hypocalcemia-in-patients-with-hypoparathyroidism-020415-4545900/ 2015-04-02T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-mvv-to-develop-potential-antimalarial-therapy-020415-4545938/ 2015-04-02T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/neurocrine-mitsubishi-tanabe-to-develop-vmat2-inhibitor-nbi-98854-for-movement-disorders-020415-4546005/ 2015-04-02T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-confirms-patent-challenge-for-generic-of-gileads-letairis-060415-4547038/ 2015-04-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-md-anderson-to-develop-new-drugs-to-treat-aml-060415-4546747/ 2015-04-06T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-establish-global-vaccines-rd-centre-in-rockville-us-060415-4546929/ 2015-04-06T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-acquires-us-rights-to-nucynta-franchise-for-105bn-from-janssen-060415-4546960/ 2015-04-06T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/schrdinger-sanofi-sign-120m-drug-discovery-deal-060415-4546994/ 2015-04-06T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-extends-deal-with-pfizer-to-develop-and-commercialize-multiple-accurins-060415-4547099/ 2015-04-06T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-lilly-to-evaluate-combination-of-demcizumab-and-alimta-to-treat-nsclc-patients-060415-4547094/ 2015-04-06T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-uniqure-enter-cardiovascular-gene-therapy-deal-070415-4547589/ 2015-04-07T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-vectibix-in-combination-with-folfiri-gets-european-approval-to-treat-mcrc-070415-4547778/ 2015-04-07T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-rtog-foundation-partner-on-phase-iiiii-trial-of-adxs-hpv-in-anal-cancer-040715-4547805/ 2015-04-07T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-seeks-fda-approval-for-pradaxa-to-treat-dvt-and-pe-070415-4547856/ 2015-04-07T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/vbi-vaccines-sanofi-pasteur-collaborate-to-improve-vaccine-stability-070415-4547898/ 2015-04-07T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-reports-positive-phase-ii-emerge-trial-of-glembatumumab-vedotin-to-treat-breast-cancer-070415-4547920/ 2015-04-07T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/neurotrope-selects-wct-to-begin-services-for-phase-iib-trial-of-bryostatin-to-treat-ad-070415-4547962/ 2015-04-07T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-merck-finalize-deal-to-co-promote-lung-cancer-drug-xalkori-080415-4548588/ 2015-04-08T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/compass-point-research-nda-partners-to-develop-migraine-combination-drug-080415-4549008/ 2015-04-08T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/celtaxsys-gets-clearance-to-start-phase-ii-acne-vulgaris-trial-of-oral-ctx-4430-080415-4549045/ 2015-04-08T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-seeks-fda-approval-for-fdc-of-emtricitabinetenofovir-alafenamide-to-treat-hiv-080415-4548913/ 2015-04-08T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-norethindrone-and-ethinyl-estradiol-tablets-in-us-080415-4549081/ 2015-04-08T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-introduces-bikini-ready-and-slimtrim-dietary-products-in-lewis-drug-stores-080415-4549156/ 2015-04-08T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-begins-phase-iib-trial-of-its-anti-il-6r-nanobody-in-patients-with-rheumatoid-arthritis-080415-4549187/ 2015-04-08T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-offers-nearly-29bn-to-acquire-irish-otc-drugmaker-perrigo-090415-4549678/ 2015-04-09T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-gets-european-approval-for-avastin-plus-chemotherapy-to-treat-advanced-cervical-cancer-090415-4549819/ 2015-04-09T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-perrigos-anda-for-hydromorphone-hci-extended-release-tablets-090415-4550075/ 2015-04-09T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/capricor-completes-patient-enrollment-in-initial-phase-of-dynamic-trial-of-heart-failure-drug-candidate-090415-4550104/ 2015-04-09T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/tracon-modifies-license-deal-with-case-western-reserve-university-090415-4550009/ 2015-04-09T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/armagens-ind-application-for-agt-181-gets-fda-acceptance-to-treat-hurler-syndrome-090415-4550034/ 2015-04-09T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/rhythm-begins-phase-iib-trial-of-relamorelin-to-treat-diabetic-gastroparesis-090415-4550137/ 2015-04-09T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-shires-lifitegrast-nda-to-treat-dry-eye-disease-in-adults-100515-4550740/ 2015-04-10T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-to-develop-hydrocodoneapap-tablets-using-limitx-technology-100415-4550995/ 2015-04-10T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics-reports-positive-longer-term-results-from-phase-ii-trial-of-imbruvica-in-wm-patients-100415-4551018/ 2015-04-10T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/cipla-eu-agrees-to-acquire-brazilian-drug-distributor-duomed-100415-4550911/ 2015-04-10T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-exelixis-carcinoma-drug-cabozantinib-100415-4551004/ 2015-04-10T04:53:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/medimmune-gets-fda-fast-track-status-for-medi8897-to-prevent-lrti-caused-by-rsv-in-infants-100415-4551055/ 2015-04-10T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-to-cut-workforce-by-25-in-us-100415-4550986/ 2015-04-10T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-opens-new-insulin-manufacturing-plant-in-russia-130415-4551798/ 2015-04-13T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-to-buy-153-million-mesoblast-shares-for-45m-130415-4552072/ 2015-04-13T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-genomics-to-analyse-large-scale-genotype-data-to-inform-drug-development-130415-4552126/ 2015-04-13T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/adamas-gets-fda-orphan-drug-status-for-ads-5102-to-treat-lid-associated-with-pd-130415-4552182/ 2015-04-13T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-gets-fda-fast-track-status-for-actimmune-to-treat-friedreichs-ataxia-130415-4552238/ 2015-04-13T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-modifies-partial-clinical-hold-on-tekmiras-tkm-ebola-ind-application-130415-4552359/ 2015-04-13T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/reata-gets-fda-orphan-drug-status-for-bardoxolone-methyl-to-treat-pah-130415-4552380/ 2015-04-13T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-uks-cancer-research-technology-partner-for-new-cancer-drugs-140415-4552822/ 2015-04-14T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-gets-fda-clearance-to-begin-phase-iib-trial-of-arc-520-to-treat-chronic-hbv-140415-4553079/ 2015-04-14T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-patientslikeme-enter-five-year-research-collaboration-140415-4552991/ 2015-04-14T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-medicines360-launch-liletta-52mg-to-prevent-pregnancy-for-up-to-three-years-140415-4553267/ 2015-04-14T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/hydra-biosciences-boehringer-to-discover-new-treatments-for-renal-diseases-and-disorders-140415-4553290/ 2015-04-14T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/recro-completes-acquisition-of-alkermes-ivim-meloxicam-and-cgmp-manufacturing-facility-140415-4553314/ 2015-04-14T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-arca-biopharmas-gencaro-to-prevent-atrial-fibrillation-140415-4553401/ 2015-04-14T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-expands-copanlisib-clinical-development-program-for-nhl-treatment-150415-4553862/ 2015-04-15T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-filing-teva-and-eagles-nda-for-bendamustine-rapid-infusion-product-150415-4554244/ 2015-04-15T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-launches-vancomycin-hydrochloride-for-injection-usp-150415-4554285/ 2015-04-15T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-to-buy-mexican-otc-firm-advanced-pharmaceuticals-and-nutritionals-150415-4554328/ 2015-04-15T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-vib-form-new-oncology-firm-to-develop-tb-403-for-pediatric-brain-tumors-150415-4554381/ 2015-04-15T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/sobi-gets-swiss-orphan-drug-designation-for-elocta-to-treat-haemophilia-a-150415-4554559/ 2015-04-15T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-merck-initiate-phase-iiiii-ebola-trial-in-sierra-leone-150415-4554519/ 2015-04-15T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-cancer-drug-tremelimumab-obtains-fda-orphan-drug-status-160415-4554915/ 2015-04-16T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-hcv-treatment-ombitasvirparitaprevirritonavir-gets-priority-review-in-japan-160415-4555309/ 2015-04-16T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-gets-fda-approval-for-heart-failure-drug-corlanor-160415-4555353/ 2015-04-16T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/eyenovia-senju-sign-license-and-development-agreement-for-ophthalmic-therapeutics-160415-4555459/ 2015-04-16T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/sellas-trojantec-to-develop-new-tr-1-anti-cancer-antennapedia-technology-160415-4555499/ 2015-04-16T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/coherus-baxter-amend-collaboration-agreement-for-etanercept-biosimilar-160415-4555526/ 2015-04-16T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-bristol-myers-select-development-candidate-for-neuropathic-pain-160415-4555614/ 2015-04-16T09:14:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-immunocore-to-evaluate-melanoma-immunotherapy-combinations-170415-4555975/ 2015-04-17T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-submits-nda-to-japanese-authorities-seeking-approval-for-bax-855-to-treat-hemophilia-a-170415-4556425/ 2015-04-17T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/cira-takeda-to-develop-ips-cell-applications-170415-4556559/ 2015-04-17T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-transfers-erbitux-rights-in-north-america-to-lilly-170415-4556594/ 2015-04-17T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-technion-to-develop-new-class-of-oncology-drugs-4556633/ 2015-04-17T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sandozs-glatopa-for-multiple-sclerosis-treatment-170415-4556760/ 2015-04-17T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/isarna-starts-first-in-human-isth0036-phase-i-trial-to-treat-glaucoma-170415-4556770/ 2015-04-17T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-astrazenecas-selumetinib-to-treat-uveal-melanoma-200415-4557020/ 2015-04-20T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-submits-sbla-to-fda-for-keytruda-to-treat-nsclc-200415-4557196/ 2015-04-20T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/rxi-pharma-gets-fda-orphan-drug-status-for-melanoma-drug-samcyprone-200415-4557110/ 2015-04-20T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/mersanas-fleximer-immunoconjugate-shows-potent-activity-in-low-her2-expressing-tumor-models-200415-4557154/ 2015-04-20T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/oncolytics-reolysin-gets-orphan-drug-designation-for-malignant-gliomas-treatment-200415-4557222/ 2015-04-20T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/medday-reports-positive-md1003-phase-iii-trial-results-in-patients-with-progressive-ms-200415-4557235/ 2015-04-20T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-jv-retains-ora-to-conduct-rgn-259gbt201-clinical-trials-in-us-200415-4557255/ 2015-04-20T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-agrees-to-sell-up-to-36bn-stake-in-sun-pharma-210415-4558150/ 2015-04-21T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/tetralogic-merck-enter-oncology-clinical-trial-collaboration-210415-4558349/ 2015-04-21T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-reports-positive-results-from-phase-iii-trial-of-ixekizumab-to-treat-psoriatic-arthritis-210415-4558381/ 2015-04-21T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/chemocentryx-begins-phase-ib-trial-of-ccx872-to-treat-pancreatic-cancer-210415-4558466/ 2015-04-21T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/oasmias-cancer-drug-paclical-gets-russian-marketing-approval-210415-4558447/ 2015-04-21T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-gets-fda-approval-for-botox-expanded-label-to-treat-upper-limb-spasticity-in-adults-210415-4558840/ 2015-04-21T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-company-gets-fda-approval-for-new-formulation-of-minocin-for-injection-210415-4558859/ 2015-04-21T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-offers-bid-to-acquire-mylan-for-401bn-220415-4559220/ 2015-04-22T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-funded-study-identifies-otc-compounds-that-may-replace-damaged-cells-220415-4559425/ 2015-04-22T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-potenza-to-develop-new-immuno-oncology-therapeutics-220415-4559481/ 2015-04-22T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-introduces-generic-hydroxyzine-tablets-220415-4559536/ 2015-04-22T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/relmada-begins-pharmacokinetic-trial-for-new-oral-formulations-of-buprenorphine-220415-4559549/ 2015-04-22T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/concordia-acquires-covis-pharma-commercial-assets-for-12bn-220415-4559574/ 2015-04-22T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-lung-cancer-drug-xalkori-gets-fda-breakthrough-therapy-status-220415-4559917/ 2015-04-22T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-launches-saxenda-injection-in-us-for-weight-management-230415-4560267/ 2015-04-23T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-filing-bayers-sbla-for-betaconnect-to-treat-rrms-230415-4560700/ 2015-04-23T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cymabay-gets-fda-orphan-drug-status-for-mbx-8025-to-treat-hypertriglyceridemia-230415-4560718/ 2015-04-23T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/strategia-begins-phase-iiia-trial-of-anti-cancer-agent-to-treat-advanced-hematologic-malignancies-230415-4560846/ 2015-04-23T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/cantx-gets-fda-orphan-drug-designation-for-cantrixil-to-treat-ovarian-cancer-230415-4560904/ 2015-04-23T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/owc-gc-group-to-develop-new-cannabinoid-based-drugs-230415-4560945/ 2015-04-23T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/triphase-begins-phase-i-trial-of-marizomib-bevacizumab-combination-to-treat-glioblastoma-230415-4560969/ 2015-04-23T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-myhep-tablets-in-india-to-treat-chronic-hepatitis-c-240415-4561399/ 2015-04-24T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-enters-into-immuno-oncology-clinical-trial-deal-with-juno-therapeutics-240415-4561712/ 2015-04-24T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-introduces-avycaz-in-us-to-treat-ciai-and-cuti-240415-4561737/ 2015-04-24T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-begins-evaluation-of-jetrea-to-treat-retinal-vein-occlusion-240415-4561767/ 2015-04-24T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-signs-manufacturing-marketing-and-distribution-deal-with-tong-240415-4561793/ 2015-04-24T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-bla-for-idarucizumab-gets-fda-priority-review-240415-4562089/ 2015-04-24T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-gets-fda-orphan-drug-status-for-dcr-ph1-to-treat-primary-hyperoxaluria-type-1-240415-4562098/ 2015-04-24T07:27:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cardiff-university-scientists-find-potential-root-cause-for-asthma-270415-4562698/ 2015-04-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/atyrs-resolaris-gets-fda-orphan-drug-designation-for-facioscapulohumeral-muscular-dystrophy-270415-4563345/ 2015-04-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/european-medicines-agency-recommends-opdivo-for-treatment-of-advanced-melanoma-270415-4562363/ 2015-04-27T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-releases-phase-iii-data-of-grazoprevirelbasvir-to-treat-chronic-hepatitis-c-virus-270415-4562875/ 2015-04-27T05:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/actavis-dur001-303-phase-3-study-of-single-dose-dalvance-for-absssi-meets-end-points-270415-4562972/ 2015-04-27T06:00:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/researchers-develop-new-model-to-investigate-cancers-earliest-stages-270415-4562974/ 2015-04-27T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/synchrogenix-teams-up-with-ciscrp-to-improve-global-medical-writing-capabilities-270415-4563048/ 2015-04-27T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-to-buy-quanticel-pharmaceuticals-for-485m-280415-4563468/ 2015-04-28T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyos-lixiana-gets-positive-chmp-opinion-to-treat-and-prevent-recurrent-vte-280415-4563818/ 2015-04-28T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-completes-nda-submission-to-fda-for-cancer-drug-candidate-mm-398-280415-4563850/ 2015-04-28T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ventirx-gets-european-orphan-drug-status-for-ovarian-cancer-drug-motolimod-280415-4563893/ 2015-04-28T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-introduces-cresemba-in-us-to-treat-invasive-aspergillosis-and-mucormycosis-280415-4563872/ 2015-04-28T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/4d-molecular-roche-to-develop-next-generation-aav-vectors-280415-4564000/ 2015-04-28T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-consumer-healthcare-introduces-nicorette-mini-lozenge-in-us-280415-4564021/ 2015-04-28T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-gets-us-patent-allowance-for-use-of-cannabidivarin-in-treating-epilepsy-280415-4564046/ 2015-04-28T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/ibio-selects-caliber-for-production-of-ibio-cfb03-for-clinical-development-280415-4564063/ 2015-04-28T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-phase-iii-trial-results-of-arzerra-in-patients-with-relapsed-cll-280415-4564076/ 2015-04-28T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-reports-data-from-phase-iii-trials-of-zerbaxa-in-cuti-and-ciai-280415-4564107/ 2015-04-28T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/eiger-bio-reports-interim-results-of-lonafarnib-ritonavir-combination-in-patients-infected-with-hepatitis-delta-virus-280415-4564112/ 2015-04-28T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-reports-positive-results-from-phase-iii-trial-of-hzsu-to-prevent-shingles-290415-4564529/ 2015-04-29T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/genzymes-substrate-reduction-therapy-gets-fda-fast-track-status-to-treat-fabry-disease-290415-4564754/ 2015-04-29T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-acquires-otc-brand-balmex-from-chattem-290415-4564768/ 2015-04-29T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-bio-paths-liposomal-grb-2-to-treat-aml-290415-4564782/ 2015-04-29T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-grants-approval-for-pivotal-to-expand-omazen-indication-290415-4564802/ 2015-04-29T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/easton-pharmaceuticals-launches-first-three-otc-products-290415-4564878/ 2015-04-29T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-argatroban-injection-in-us-290415-4564885/ 2015-04-29T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/co-d-therapeutics-gets-fda-orphan-drug-status-for-triolimus-to-treat-angiosarcoma-290415-4564895/ 2015-04-29T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-otonomys-nda-for-auripro-to-treat-middle-ear-effusion-in-pediatric-patients-290415-4564903/ 2015-04-29T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-divests-development-stage-imaging-agent-nav5001-for-parkinsons-disease-290415-4564914/ 2015-04-29T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/constellation-begins-phase-i-trial-of-cpi-1205-in-lymphoma-patients-290415-4564839/ 2015-04-29T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/imprimis-gets-exclusive-us-rights-to-hep-lido-a-formulation-from-urigen-to-treat-interstitial-cystitis-290415-4564869/ 2015-04-29T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-agrees-to-pay-24bn-to-settle-actos-cancer-claims-300415-4565602/ 2015-04-30T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-gets-nutrition-house-approval-to-expand-full-tapout-line-across-canada-300415-4565911/ 2015-04-30T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/irish-otc-firm-perrigo-rejects-mylans-raised-bid-300415-4565835/ 2015-04-30T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-brilinta-gets-fda-priority-review-for-potential-new-indication-300415-4565954/ 2015-04-30T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/kythera-gets-fda-approval-for-kybella-to-treat-submental-fat-300415-4565863/ 2015-04-30T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-bristol-myers-sbla-for-melanoma-drug-opdivo-300415-4565974/ 2015-04-30T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-begins-patient-enrolment-in-revised-us-phase-iii-trial-of-cancer-drug-xilonix-300415-4566012/ 2015-04-30T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-biogen-and-abbvies-bla-for-zinbryta-to-treat-multiple-sclerosis-300415-4566153/ 2015-04-30T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/benitec-doses-fifth-patient-in-phase-iiia-trial-of-tt-034-to-treat-hepatitis-c-virus-300415-4566164/ 2015-04-30T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-to-review-amgens-bla-for-repatha-as-treatment-for-high-cholesterol-300415-4566176/ 2015-04-30T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-pharmaceuticals-gets-new-patent-for-zorvolex-from-uspto-300415-4566192/ 2015-04-30T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/contrafect-begins-phase-i-trial-of-cf-301-for-staph-bloodstream-infections-300415-4566202/ 2015-04-30T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-and-theravances-breo-ellipta-gets-fda-approval-to-treat-asthma-in-adults-010515-4566560/ 2015-05-01T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/arno-gets-european-orphan-drug-status-for-ar-12-to-treat-cryptococcosis-and-tularaemia-010515-4566774/ 2015-05-01T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/lycera-begins-phase-i-trial-of-lyc-30937-to-treat-inflammatory-bowel-disease-010515-4566814/ 2015-05-01T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/cypher-pennsylvania-university-partner-to-discover-genetic-factors-in-psp-010515-4566786/ 2015-05-01T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-biologics-begins-construction-of-new-biologics-manufacturing-facility-in-china-010515-4566857/ 2015-05-01T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/tesaro-completes-target-enrollment-in-phase-iii-nova-trial-begins-quadra-trial-of-niraparib-010515-4566943/ 2015-05-01T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharmas-otc-drug-nyloxin-gets-acceptance-from-cpam-010515-4566956/ 2015-05-01T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/theraclone-to-use-i-star-technology-to-discover-therapeutic-antibodies-against-ebola-virus-010515-4566894/ 2015-05-01T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/lipocine-completes-phase-iii-trial-of-oral-testosterone-lpcn-1021-010515-4567059/ 2015-05-01T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ocata-therapeutics-reports-positive-results-in-treating-macular-degeneration-using-rpe-cells-010515-4567078/ 2015-05-01T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/georgia-tech-research-provides-new-cellular-sensing-platform-to-develop-next-generation-bioscience-and-biotech-applications-010515-4567086/ 2015-05-01T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/taigen-begins-phase-iii-trial-of-burixafor-in-china-to-treat-acute-myeloid-leukemia-010515-4566923/ 2015-05-01T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/oncobiologics-opens-gmp-commercial-launch-manufacturing-facility-in-cranbury-us-040515-4569130/ 2015-05-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/allegro-starts-phase-ii-trial-of-luminate-for-non-proliferative-diabetic-retinopathy-040515-4569147/ 2015-05-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/generon-gets-fda-clearance-to-begin-phase-iia-trial-with-f-652-to-treat-acute-gvhd-040515-4569161/ 2015-05-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/peptidream-merck-enter-into-peptide-discovery-collaboration-040515-4567669/ 2015-05-04T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-reports-positive-results-from-phase-iii-trial-of-revlmid-in-patients-with-non-del-5q-mds-040515-4567801/ 2015-05-04T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-vernalis-and-tris-nda-for-tuzistra-xr-for-relief-of-cough-040515-4567837/ 2015-05-04T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/braeburn-expands-therapeutic-pipeline-with-two-schizophrenia-treatments-040515-4567867/ 2015-05-04T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-tentative-approval-for-amerigens-generic-toviaz-040515-4567925/ 2015-05-04T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-takes-over-south-american-rights-to-cynviloq-from-samyang-040515-4567948/ 2015-05-04T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/aits-high-dose-nitric-oxide-formulation-gets-european-orphan-drug-status-to-treat-cystic-fibrosis-040515-4567826/ 2015-05-04T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/myelin-repair-foundation-and-nih-begin-clinical-studies-of-guanabenz-to-treat-multiple-sclerosis-040515-4568338/ 2015-05-04T09:31:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-reports-positive-data-on-tarextumabs-anti-cancer-stem-cell-activity-in-clinical-cancer-research-040515-4568339/ 2015-05-04T09:38:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-begins-construction-of-223m-manufacturing-plant-in-denmark-050515-4568551/ 2015-05-05T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/kadmon-begins-second-phase-ii-trial-of-kd026-to-treat-type-2-diabetes-050515-4568752/ 2015-05-05T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-begins-expansion-stage-of-phase-ii-trial-for-new-aml-treatment-050515-4568790/ 2015-05-05T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-gileads-sovaldi-tablets-in-india-to-treat-chronic-hepatitis-c-infection-050515-4568829/ 2015-05-05T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mjff-prothena-to-accelerate-new-biomarkers-discovery-for-parkinsons-disease-050515-4568814/ 2015-05-05T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/aquinox-completes-patient-enrollment-in-phase-ii-trial-of-aqx-1125-to-treat-atopic-dermatitis-050515-4568850/ 2015-05-05T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-to-develop-isis-pharmaceuticals-isis-fxi-rx-for-prevention-of-thrombosis-050515-4568927/ 2015-05-05T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-xarelto-gets-chinese-approval-for-stroke-prevention-in-patients-with-non-valvular-atrial-fibrillation-to-treat-dvt-050515-4568962/ 2015-05-05T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-bioscience-merrimack-seek-european-approval-for-pancreatic-cancer-treatment-mm-398-050515-4569081/ 2015-05-05T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-reports-positive-interim-analysis-from-two-ongoing-phase-ib-aldoxorubicin-combination-studies-050515-4569096/ 2015-05-05T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/cortex-reports-research-results-on-use-of-ampakines-cx1739-and-cx717-to-treat-respiratory-disorders-050515-4569105/ 2015-05-05T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/makindus-gets-european-orphan-drug-status-for-mi-100-to-treat-stargardts-disease-050515-4569118/ 2015-05-05T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-23andme-launch-lupus-research-study-060515-4569593/ 2015-05-06T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-completes-takeover-of-auspex-pharmaceuticals-for-32bn-060515-4569985/ 2015-05-06T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/arqule-beryllium-enter-research-and-development-agreement-for-immuno-oncology-targets-060515-4570032/ 2015-05-06T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ora-to-develop-portolas-syk-selective-inhibitor-in-ophthalmic-diseases-060515-4570057/ 2015-05-06T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-begins-phase-ii-trial-of-mm-141-to-treat-pancreatic-cancer-060515-4570075/ 2015-05-06T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-begins-transition-to-patients-in-phase-i-trial-of-arc-aat-to-treat-liver-disease-060515-4570170/ 2015-05-06T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/retrophin-gets-fda-orphan-drug-status-for-re-024-to-treat-pkan-060515-4570187/ 2015-05-06T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-reports-positive-results-from-phase-iii-trial-of-humira-060515-4570455/ 2015-05-06T09:55:00+00:00 https://www.pharmaceutical-business-review.com/news/cytodyn-submits-phase-iii-protocol-to-fda-after-agreement-on-protocol-synopsis-060515-4570458/ 2015-05-06T10:01:00+00:00 https://www.pharmaceutical-business-review.com/news/amarantus-gets-notice-of-allowance-for-uspto-covering-proprietary-compositions-of-matter-and-methods-of-use-for-manf-060515-4570459/ 2015-05-06T10:05:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-health-takesover-eirgen-pharma-060515-4570460/ 2015-05-06T10:09:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-to-develop-c1-esterase-inhibitor-c1-inh-as-next-plasma-derived-drug-candidate-070515-4574056/ 2015-05-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-drops-plans-to-sell-viiv-hiv-drugs-unit-070515-4570683/ 2015-05-07T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-agrees-to-buy-synageva-biopharma-for-84bn-070515-4570867/ 2015-05-07T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-starts-phase-iii-program-with-dolutegravirrilpivirine-combination-to-treat-hiv-070515-4570918/ 2015-05-07T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-to-build-new-innovation-center-in-cambridge-us-070515-4570954/ 2015-05-07T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-gets-fda-breakthrough-therapy-status-for-venetoclax-to-treat-cll-070515-4570890/ 2015-05-07T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-to-buy-epitherapeutics-for-65m-070515-4570981/ 2015-05-07T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-begins-co-promotion-of-pfizers-cancer-drug-xalkori-in-us-070515-4571019/ 2015-05-07T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-launches-virirec-in-spain-to-treat-erectile-dysfunction-070515-4571069/ 2015-05-07T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/the-transformative-promise-of-patient-centric-rd-070515-4571105/ 2015-05-07T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/parion-begins-phase-ii-trial-of-p-1037-to-treat-cystic-fibrosis-070515-4571605/ 2015-05-07T09:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-reports-positive-results-from-phase-iii-trial-of-nulojix-070515-4571606/ 2015-05-07T09:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-grants-gen-ilac-rights-to-distribute-iclusig-in-turkey-070515-4571607/ 2015-05-07T09:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-genetics-enters-into-research-collaboration-with-moffitt-cancer-center-070515-4571608/ 2015-05-07T09:52:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-to-re-launch-generic-pulmicort-respules-after-favorable-appeals-court-ruling-080515-4573227/ 2015-05-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/esperion-engages-myrtle-potter-for-development-of-etc-1002-commercialization-strategy-080515-4573231/ 2015-05-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-completes-hyperion-therapeutics-acquisition-080515-4573236/ 2015-05-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medicinova-completes-patient-enrollment-in-phase-iib-trial-of-ibudilast-in-progressive-ms-080515-4573242/ 2015-05-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-plexxikon-to-evaluate-immuno-oncology-combination-regimen-080515-4571814/ 2015-05-08T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/alzheimers-disease-treatment-market-value-will-exceed-13bn-by-2023-says-globaldata-080515-4571853/ 2015-05-08T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-emd-serono-finalize-promotional-services-agreement-for-saizen-in-us-080515-4572206/ 2015-05-08T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-gets-fda-fast-track-status-for-cobiprostone-to-prevent-oral-mucositis-080515-4572131/ 2015-05-08T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-acquires-rights-to-iurtcs-next-generation-gentamicin-derivatives-080515-4572159/ 2015-05-08T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/cyclenium-enters-into-drug-discovery-collaboration-with-haplogen-080515-4572083/ 2015-05-08T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/siegfried-agrees-to-buy-basf-drug-ingredient-businesses-for-eur270m-080515-4571943/ 2015-05-08T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sumitomo-dainippon-takeda-to-terminate-joint-development-deal-of-latuda-080515-4572111/ 2015-05-08T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-discovery-thermo-fisher-enter-supply-and-commercialization-agreement-110515-4573582/ 2015-05-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-unc-chapel-partner-to-accelerate-search-for-hiv-cure-110515-4572934/ 2015-05-11T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/selvita-establishes-uk-subsidiary-in-cambridge-110515-4573246/ 2015-05-11T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-reports-positive-data-from-a-post-hoc-analysis-of-phase-iiia-scale-trial-of-saxenda-110515-4573252/ 2015-05-11T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-avelox-to-treat-patients-with-plague-110515-4573262/ 2015-05-11T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/tga-approves-akynzeo-to-prevent-chemotherapy-induced-nausea-and-vomiting-cinv-110515-4573269/ 2015-05-11T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-enters-into-settlement-and-license-agreement-with-perrigo-for-pennsaid-2-patent-litigation-110515-4573284/ 2015-05-11T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-novartis-lung-cancer-drug-zykadia-110515-4573377/ 2015-05-11T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/otonomy-closes-patient-enrollment-in-phase-ii-trial-of-auripro-to-treat-aomt-110515-4573319/ 2015-05-11T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-lifts-clinical-hold-on-neuroderms-nd0612-to-treat-parkinsons-disease-110515-4573446/ 2015-05-11T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-national-cancer-center-of-japan-to-discover-new-anti-cancer-agents-110515-4573405/ 2015-05-11T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/steadymed-seeks-orphan-drug-designation-from-fda-for-trevyent-to-treat-pah-110515-4573487/ 2015-05-11T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-minority-stake-in-dutch-biotech-firm-am-pharma-120515-4573954/ 2015-05-12T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-biontech-enter-research-deal-for-new-cancer-immunotherapies-120515-4573981/ 2015-05-12T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/juno-therapeutics-acquires-stage-cell-therapeutics-120515-4574413/ 2015-05-12T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/gloria-to-develop-and-commercialize-sucampos-amitiza-in-china-120515-4574442/ 2015-05-12T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-enters-into-research-partnership-with-sutter-health-120515-4574490/ 2015-05-12T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-novocures-pma-application-of-optune-120515-4574513/ 2015-05-12T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/heat-biologics-begins-phase-ib-trial-of-viagenpumatucel-l-to-treat-nsclc-120515-4574550/ 2015-05-12T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/ose-pharma-signs-licensing-distribution-deal-with-rafa-laboratories-in-isral-for-tedopi-120515-4575002/ 2015-05-12T09:54:00+00:00 https://www.pharmaceutical-business-review.com/news/curemark-launches-new-phase-iii-trial-in-expanded-population-of-children-with-autism-120515-4575004/ 2015-05-12T09:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ophthotech-completes-patient-recruitment-of-first-phase-iii-trial-of-fovista-120515-4575006/ 2015-05-12T10:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-qidp-and-fast-track-status-for-cidaras-antifungal-product-candidate-cd101-iv-120515-4575008/ 2015-05-12T10:11:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-biopharma-gets-ema-orphan-medicine-designation-for-ampligen-to-treat-ebola-virus-disease-120515-4575010/ 2015-05-12T10:15:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-reports-positive-interim-results-from-phase-ii-poplar-study-in-people-with-nsclc-130515-4576914/ 2015-05-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordic-gets-50m-eib-loan-for-new-vaccines-against-ebola-130515-4576931/ 2015-05-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-mercks-pancreatic-cancer-drug-evofosfamide-130515-4575210/ 2015-05-13T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/seabuckwonders-unveils-new-hair-skin-nails-supplement-in-us-130515-4575540/ 2015-05-13T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-takes-over-mexican-operations-of-patheon-for-34m-130515-4575507/ 2015-05-13T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharmas-tapout-products-now-available-in-300-plus-fitness-centers-across-north-america-130515-4575520/ 2015-05-13T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/cyclenium-astellas-pharma-enter-into-drug-discovery-collaboration-130515-4575627/ 2015-05-13T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-begins-patient-enrolment-in-phase-iii-trial-of-myeloma-drug-ixazomib-130515-4575557/ 2015-05-13T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-bioscience-to-acquire-cancer-drugs-from-sigma-tau-finanziaria-for-900m-130515-4575606/ 2015-05-13T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrocell-gets-fda-rare-pediatric-disease-designation-for-fcx-007-to-treat-rdeb-130515-4576270/ 2015-05-13T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiome-aop-orphan-pharma-enter-esmocard-commercialization-agreement-130515-4576278/ 2015-05-13T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/relmada-gets-notice-of-allowance-for-us-patent-covering-securel-technology-platform-for-opioids-130515-4576281/ 2015-05-13T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-oxford-university-and-emergent-begin-phase-i-trial-of-ebola-vaccine-candidates-140515-4576555/ 2015-05-14T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cel-sci-gets-approval-to-begin-phase-iii-multikine-trial-in-italy-140515-4576942/ 2015-05-14T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-begins-phase-i-trial-of-bcx7353-to-treat-hereditary-angioedema-140515-4576960/ 2015-05-14T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-mhi-to-screen-80000-samples-for-cardiovascular-and-diabetes-genetic-traits-140515-4576975/ 2015-05-14T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/lcs-group-to-commercialize-813-patent-and-249-application-for-binge-eating-disorder-140515-4577002/ 2015-05-14T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharmaceuticals-takes-over-rights-to-testosterone-gel-1-140515-4577020/ 2015-05-14T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-to-promote-paragon-biotecks-ilast-products-in-us-140515-4576787/ 2015-05-14T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-to-market-bioquidditys-two-ready-to-use-infusion-products-in-us-140515-4576779/ 2015-05-14T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-discontinue-phase-iii-trial-of-alisertib-in-relapsed-or-refractory-ptcl-patients-140515-4576707/ 2015-05-14T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/therabrons-cg100-gets-ema-orphan-drug-status-to-prevent-bronchopulmonary-dysplasia-140515-4576835/ 2015-05-14T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-enrols-first-patient-in-re-circuit-trial-of-dabigatran-etexilate-to-treat-af-140515-4576638/ 2015-05-14T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordic-reports-positive-results-from-two-clinical-trials-of-imvamune-smallpox-vaccine-140515-4576808/ 2015-05-14T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-gets-provisional-license-from-uruguayan-government-for-rdof-prescription-cannabinoid-medicines-150515-4578727/ 2015-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amarantus-enters-into-cgmp-manufacturing-deal-with-catalent-biologics-for-manf-150515-4578729/ 2015-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/stemcells-reports-positive-top-line-results-of-thoracic-spinal-cord-injury-phase-iii-trial-150515-4578733/ 2015-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/d-pharm-gets-final-report-for-phase-ii-trial-of-thr-18-in-acute-stroke-patients-treated-with-tpa-150515-4578739/ 2015-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-sanford-burnham-partner-to-develop-new-immunological-therapies-150515-4577729/ 2015-05-15T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fibromyalgia-treatment-market-value-will-crawl-to-19bn-by-2023-says-globaldata-150515-4577935/ 2015-05-15T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-gets-acceptance-in-scotland-for-trajenta-insulin-combination-to-treat-t2d-150515-4577796/ 2015-05-15T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/adynxx-completes-enrollment-in-phase-ii-trial-of-ayx1-to-prevent-post-surgical-pain-150515-4578217/ 2015-05-15T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/cortendo-to-develop-antisenses-atl1103-for-acromegaly-150515-4578157/ 2015-05-15T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/glycomimetics-gmi-1271-gets-fda-orphan-drug-status-to-treat-aml-150515-4578195/ 2015-05-15T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/epirus-mabxience-enter-distribution-deal-for-infliximab-biosimilar-in-latin-america-150515-4578246/ 2015-05-15T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-launches-zorvolex-in-lebanon-for-acute-and-chronic-pain-150515-4578272/ 2015-05-15T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/tissuegene-enters-spa-agreement-with-fda-for-phase-iii-trial-of-invossa-to-treat-osteoarthritis-of-the-knee-180515-4579831/ 2015-05-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-phase-ii-trial-data-for-amg-334-for-prevention-of-episodic-migraine-180515-4579840/ 2015-05-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mtti-gets-expanded-patent-approval-for-99mtc-duramycin-technology-to-target-programmed-cell-death-180515-4579859/ 2015-05-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanbio-gets-key-patent-from-uspto-for-new-treatment-for-chronic-stroke-180515-4579871/ 2015-05-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-reports-positive-interim-results-from-phase-ii-trial-of-mpdl3280a-180515-4579881/ 2015-05-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-baxters-additional-manufacturing-site-for-sodium-chloride-injection-in-us-180515-4578915/ 2015-05-18T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-gets-fda-orphan-drug-status-for-humira-to-treat-hidradenitis-suppurativa-180515-4578972/ 2015-05-18T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-seeks-mhra-approval-for-aln-aat-phase-iii-trial-to-treat-alpha-1-liver-disease-180515-4579292/ 2015-05-18T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pernixs-treximet-gets-fda-approval-to-treat-migraine-in-pediatric-patients-180515-4579353/ 2015-05-18T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-gets-fda-fast-track-status-for-lung-cancer-drug-sacituzumab-govitecan-180515-4579327/ 2015-05-18T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/zambon-and-newron-launch-xadago-in-germany-to-treat-mid-to-late-stage-parkinsons-disease-180515-4579386/ 2015-05-18T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-new-vial-size-of-csl-behrings-berinert-to-treat-hereditary-angioedema-180515-4579412/ 2015-05-18T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-acquires-pharmaxis-phase-1-anti-inflammatory-drug-candidate-190515-4580812/ 2015-05-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-signs-definitive-agreement-to-buy-silarx-pharmaceuticals-190515-4580833/ 2015-05-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hedgepath-to-receive-25m-in-funding-from-mayne-pharma-190515-4580842/ 2015-05-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/durect-reports-positive-results-from-dur-928-multi-dose-phase-i-trial-200515-4580844/ 2015-05-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-study-shows-link-between-improving-health-status-and-reduced-mortality-in-copd-patients-190515-4580851/ 2015-05-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-build-285m-biologics-manufacturing-facility-in-sweden-190515-4579983/ 2015-05-19T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-introduces-namzaric-in-us-to-treat-moderate-to-severe-alzheimers-disease-190515-4580377/ 2015-05-19T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-genzyme-collaborate-on-multiple-sclerosis-research-project-190515-4580409/ 2015-05-19T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/abgenomics-begins-phase-ibiia-trial-of-neihulizumab-to-treat-steroid-refractory-agvhd-190515-4580440/ 2015-05-19T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/radiomedix-areva-med-to-develop-new-treatment-against-nets-190515-4580479/ 2015-05-19T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/kura-oncology-begins-dosing-in-phase-ii-tipifarnib-trial-to-treat-tumors-with-hras-mutations-190515-4580565/ 2015-05-19T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/corbus-gets-fda-nod-to-begin-phase-ii-trial-of-resunab-to-treat-cystic-fibrosis-190515-4580512/ 2015-05-19T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-distribute-kaketsukens-seasonal-influenza-vaccine-in-japan-200515-4581164/ 2015-05-20T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-biontech-to-develop-bispecific-antibody-products-using-duobody-technology-200515-4581225/ 2015-05-20T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-achillion-to-develop-new-oral-regimens-to-treat-hepatitis-c-virus-200515-4581442/ 2015-05-20T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-to-submit-rolling-nda-for-eteplirsen-to-treat-dmd-200515-4581456/ 2015-05-20T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/vtv-therapeutics-begins-phase-iii-trial-of-azeliragon-to-treat-mild-alzheimers-disease-200515-4581476/ 2015-05-20T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/glycomimetics-begins-phase-iii-trial-of-gmi-1271-to-treat-aml-200515-4581499/ 2015-05-20T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/octc-bryla-cmc-reg-consulting-to-deliver-cmc-services-for-pharmaceutical-industry-200515-4581509/ 2015-05-20T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/melintas-phase-iii-trial-shows-significant-burden-of-obesity-on-patients-recovery-from-absssi-200515-4581521/ 2015-05-20T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/alcyone-lifesciences-dnatrix-enter-clinical-collaboration-for-brain-cancer-200515-4581530/ 2015-05-20T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-signs-long-term-manufacturing-deal-with-prometic-life-sciences-200515-4581534/ 2015-05-20T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-muscle-maker-grill-introduce-new-booster-supplements-product-line-200515-4581543/ 2015-05-20T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-reports-positive-results-for-latuda-in-first-placebo-controlled-trial-in-mdd-patients-200515-4581552/ 2015-05-20T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-introduces-in-house-developed-thyroid-cancer-drug-lenvima-in-japan-210515-4582095/ 2015-05-21T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-alnylams-revusiran-to-treat-ttr-mediated-amyloidosis-210515-4582240/ 2015-05-21T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-gets-amended-fda-breakthrough-therapy-status-for-daclatasvir-based-hcv-regimen-210515-4582255/ 2015-05-21T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/faron-china-medical-system-to-develop-traumakine-to-treat-ards-210515-4582298/ 2015-05-21T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/biomay-to-use-vtu-pichia-strains-to-produce-recombinant-allergens-210515-4582275/ 2015-05-21T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/discovery-labs-begins-patient-enrollment-in-phase-iia-dose-expansion-trial-of-aerosurf-210515-4582330/ 2015-05-21T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/immunoclin-to-offer-cro-services-for-part-ii-of-phase-i-crotoxin-trial-for-celtic-biotech-210515-4582362/ 2015-05-21T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/plasmatechs-lead-product-candidates-get-fda-orphan-drug-and-rare-pediatric-disease-designations-21515-4582378/ 2015-05-21T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/signalrx-gets-sttr-grant-from-nih-to-develop-dual-pi3-kinasebromodomain-inhibitors-as-anticancer-agents-210515-4582383/ 2015-05-21T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/precision-biologics-completes-patient-accrual-to-ensituximab-phase-ii-colorectal-cancer-trial-210515-4582394/ 2015-05-21T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/aphios-gets-us-patent-for-alzheimers-disease-treatment-210515-4582403/ 2015-05-21T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-partner-menarini-asia-pacific-introduces-kerasal-nail-in-china-210515-4582418/ 2015-05-21T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/novare-enters-into-research-agreement-with-lawson-health-research-institute-220515-4583732/ 2015-05-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vical-completes-enrollment-in-phase-ii-trial-of-investigational-cmv-vaccine-220515-4583743/ 2015-05-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eureka-therapeutics-to-develop-new-antibodies-for-cancer-treatment-220515-4583048/ 2015-05-22T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-bioscience-submits-maa-in-europe-for-igsc-20-to-treat-primary-immunodeficiency-220515-4583193/ 2015-05-22T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/wockhardt-gets-fda-qidp-status-for-new-pneumonia-drug-wck-4873-220515-4583147/ 2015-05-22T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/strides-arcolab-to-buy-aspens-generic-drugs-business-in-australia-for-300m-220515-4583326/ 2015-05-22T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/aura-biosciences-gets-fda-orphan-disease-designation-for-au-011-to-treat-uveal-melanoma-220515-4583417/ 2015-05-22T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-begins-dosing-in-phase-iii-trial-of-kte-c19-to-treat-refractory-aggressive-nhl-220515-4583435/ 2015-05-22T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-tris-pharmas-nda-for-dyanavel-xr-to-treat-adhd-220515-4583502/ 2015-05-22T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/tribute-acquires-us-rights-to-fibricor-and-commercial-expansion-into-us-market-220515-4583725/ 2015-05-22T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-reports-positive-study-results-on-optina-to-treat-diabetic-macular-edema-220515-4583729/ 2015-05-22T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/highland-therapeutics-gets-three-us-patents-and-one-notice-of-allowance-220515-4583737/ 2015-05-22T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-seeks-japanese-approval-for-eosinophilic-asthma-drug-mepolizumab-250515-4584217/ 2015-05-25T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinion-for-mercks-keytruda-to-treat-advanced-melanoma-250515-4584393/ 2015-05-25T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-gets-chmp-positive-opinion-for-lung-cancer-drug-nivolumab-250515-4584324/ 2015-05-25T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-psoriasis-drug-stelara-gets-chmp-positive-opinion-to-treat-adolescents-250515-4584410/ 2015-05-25T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-omidria-gets-ema-committee-positive-opinion-for-cataract-and-iol-procedures-250515-4584442/ 2015-05-25T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiorentis-completes-patient-enrollment-in-phase-iii-trial-of-heart-failure-drug-ularitide-250515-4584506/ 2015-05-25T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/rhodes-to-launch-adhd-treatment-aptensio-xr-this-summer-250515-4584571/ 2015-05-25T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-gets-chmp-positive-ppinion-for-repatha-to-treat-high-cholesterol-250515-4584775/ 2015-05-25T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-to-terminate-participation-in-co-development-and-commercialization-of-brodalumab-with-astrazeneca-250515-4584763/ 2015-05-25T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-biomedicine-reports-positive-phase-i-results-from-car-t-cd30-immuno-oncology-clinical-development-program-250515-4584770/ 2015-05-25T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-sanofi-report-positive-topline-results-from-phase-iii-trials-with-sarilumab-in-patients-with-rheumatoid-arthritis-250515-4584779/ 2015-05-25T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-confirms-appeals-court-ruling-requiring-continued-distribution-of-namenda-ir-250515-4584759/ 2015-05-25T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-introduces-new-solution-to-meet-needs-of-biopharmaceutical-firms-in-asia-pacific-260515-4585987/ 2015-05-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pei-funds-treatment-with-aubagio-for-relapsing-remitting-multiple-sclerosis-260515-4585992/ 2015-05-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/intellipharmaceutics-to-buy-land-for-manufacturing-rd-and-office-facilities-in-toronto-260515-4585999/ 2015-05-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-ind-to-critical-outcome-technologies-for-activator-of-mutant-p53-protein-coti-2-260515-4586936/ 2015-05-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/r-tech-ueno-completes-phase-i-single-dose-trial-for-new-vap-1-inhibitor-rtu-1096-260515-4585180/ 2015-05-26T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/tanner-burnsadler-merge-to-form-new-tanner-pharma-group-260515-4585246/ 2015-05-26T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/united-therapeutics-unituxin-gets-ema-marketing-authorization-to-treat-neuroblastoma-260515-4585606/ 2015-05-26T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/visterra-astar-to-develop-monoclonal-antibody-vis513-to-treat-dengue-260515-4585634/ 2015-05-26T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ergomed-takes-over-medical-information-service-provider-sound-opinion-260515-4585673/ 2015-05-26T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-cerulean-pharmas-ovarian-cancer-drug-crlx101-260515-4585724/ 2015-05-26T09:12:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-sanofi-enter-commercialization-deal-for-ciclomulsion-in-south-korea-260515-4585777/ 2015-05-26T09:12:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-acquires-cancer-drugmaker-pharmacyclics-for-21bn-270515-4586126/ 2015-05-27T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacenter-to-begin-marketing-eastgates-nutraceutical-products-270515-4586354/ 2015-05-27T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/sophiris-bio-begins-dosing-in-phase-iia-proof-of-concept-prostate-cancer-trial-of-prx302-270515-4586388/ 2015-05-27T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-stiolto-respimat-gets-fda-approval-for-copd-treatment-270515-4586413/ 2015-05-27T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-cambridge-university-partner-to-facilitate-breakthrough-biopharmaceutical-research-270515-4586441/ 2015-05-27T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/synageva-submits-nda-in-japan-for-kanuma-to-treat-lal-deficiency-270515-4586469/ 2015-05-27T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/zs-pharma-files-nda-to-us-fda-for-zs-9-to-treat-hyperkalemia-270515-4586485/ 2015-05-27T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-submits-protocol-to-fda-for-phase-iib-oral-insulin-study-270515-4586839/ 2015-05-27T09:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-receives-aurobindo-request-to-use-dolutegravir-for-hiv-treatment-270515-4586847/ 2015-05-27T09:44:00+00:00 https://www.pharmaceutical-business-review.com/news/rani-therapeutics-novartis-partner-to-test-oral-biotherapeutics-drug-delivery-platform-4586854/ 2015-05-27T09:46:00+00:00 https://www.pharmaceutical-business-review.com/news/generex-nhtherapeutics-team-up-to-use-rapidmist-buccal-delivery-technology-for-leuprolide-4586860/ 2015-05-27T09:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ocata-gets-three-new-us-patents-for-rpe-therapy-for-macular-degenerative-diseases-270515-4586935/ 2015-05-27T09:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sciclone-to-develop-and-commercialize-theravances-vibativ-in-china-280515-4587139/ 2015-05-28T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-actavis-viberzi-to-treat-irritable-bowel-syndrome-with-diarrhea-in-adults-280515-4587446/ 2015-05-28T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/otsukas-jinarc-gets-european-marketing-authorization-to-treat-adpkd-280515-4587462/ 2015-05-28T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-gets-ema-committee-positive-opinion-for-fycompa-to-treat-pgtc-seizures-280515-4587509/ 2015-05-28T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-salixs-xifaxan-550mg-to-treat-ibs-d-in-adults-280515-4587607/ 2015-05-28T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-geneone-life-science-partner-for-mers-immunotherapy-clinical-development-280515-4587546/ 2015-05-28T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/innocrin-begins-phase-ii-trial-of-prostate-cancer-drug-candidate-vt-464-280515-4587637/ 2015-05-28T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/water-street-enters-into-pharmaceutical-development-partnership-280515-4588064/ 2015-05-28T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/aacr-bayer-to-fund-fellowships-to-advance-cancer-research-280515-4588065/ 2015-05-28T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/akron-biotech-enters-into-strategic-partnership-with-cognate-bioservices-280515-4588068/ 2015-05-28T09:00:00+00:00 https://www.pharmaceutical-business-review.com/news/regen-biopharma-files-patent-application-on-mrna-dendritic-cell-cancer-immunotherapeutic-280515-4588071/ 2015-05-28T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/beryllium-develops-mcl-1-platform-for-structure-guided-drug-discovery-280515-4588075/ 2015-05-28T09:13:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-gets-european-patent-for-kerasal-nail-290515-4590316/ 2015-05-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-launches-type-2-diabetes-drug-zafatek-in-japan-290515-4588337/ 2015-05-29T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/galenica-to-commercialize-roches-mircera-in-us-and-puerto-rico-290515-4588612/ 2015-05-29T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-and-lillys-type-2-diabetes-drug-synjardy-gets-european-marketing-authorization-290515-4588539/ 2015-05-29T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-begins-phase-iii-trial-of-varlilumab-sunitinib-combination-to-treat-cc-rcc-290515-4588567/ 2015-05-29T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-grant-3m-for-further-advanced-breast-cancer-research-290515-4588635/ 2015-05-29T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-and-janssen-extend-clinical-investigation-of-cancer-drug-xarelto-290515-4588685/ 2015-05-29T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-launches-program-to-further-advance-basic-biology-research-290515-4589176/ 2015-05-29T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-michigan-of-to-study-mechanisms-of-diabetic-nephropathy-in-pima-indians-290515-4589181/ 2015-05-29T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ultragenyx-gets-first-patient-enrolled-in-phase-iii-trial-of-sialic-acid-extended-release-in-gne-myopathy-290515-4589196/ 2015-05-29T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabics-files-patent-application-which-covers-new-personalized-anti-cancer-treatment-290515-4589202/ 2015-05-29T08:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-gileads-maa-for-fixed-dose-combination-of-emtricitabine-and-tenofovir-alafenamide-290515-4588858/ 2015-05-29T09:25:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-launches-argatroban-injection-in-us-010615-4591101/ 2015-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-phase-iii-trial-results-of-palbociclib-in-patients-with-hr-her2-metastatic-breast-cancer-010615-4593794/ 2015-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/portola-reports-updated-data-from-ongoing-phase-iiia-trial-of-dual-kinase-inhibitor-cerdulatinib-010615-4593800/ 2015-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-lilly-to-conduct-phase-i-immuno-oncology-combination-trial-to-treat-solid-tumors-010615-4589425/ 2015-06-01T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/tesaro-merck-to-conduct-phase-iii-trial-of-niraparib-and-keytruda-for-breast-and-ovarian-cancers-010615-4589839/ 2015-06-01T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-begins-phase-iii-trial-of-multiple-myeloma-drug-kyprolis-010615-4589736/ 2015-06-01T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaengine-seeks-approval-for-mm-398-in-taiwan-to-treat-post-gemcitabine-pancreatic-cancer-010615-4589786/ 2015-06-01T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-generic-lomedia-24-fe-tablets-to-prevent-pregnancy-010615-4589912/ 2015-06-01T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-reports-positive-phase-iii-trial-results-of-lung-cancer-drug-opdivo-010615-4589947/ 2015-06-01T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-releases-positive-results-from-phase-ii-trial-of-lung-cancer-drug-cabozantinib-010615-4589999/ 2015-06-01T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-reports-phase-iii-trial-data-of-asp2215-to-treat-patients-with-aml-010615-4590307/ 2015-06-01T10:02:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-data-from-phase-iii-combi-d-trial-in-patients-with-metastatic-melanoma-010615-4590313/ 2015-06-01T10:11:00+00:00 https://www.pharmaceutical-business-review.com/news/eisais-thyroid-cancer-drug-lenvima-gets-approval-in-europe-020615-4590518/ 2015-06-02T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-begins-patient-enrollment-to-trial-drug-for-low-testosterone-levels-020615-4590564/ 2015-06-02T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-completes-auden-mckenzie-acquisition-for-306m-020615-4590620/ 2015-06-02T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-bristol-myers-application-for-opdivoyervoy-regimen-for-advanced-melanoma-020615-4590887/ 2015-06-02T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-generic-actonel-tablets-in-us-020615-4590897/ 2015-06-02T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-and-dynavax-to-evaluate-combined-immuno-oncology-therapies-020615-4590942/ 2015-06-02T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-reports-results-from-phase-ii-trial-of-veliparib-in-patients-with-nsclc-020615-4591038/ 2015-06-02T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/nuovo-biologics-auburn-university-partner-to-develop-new-cancer-therapies-020615-4590990/ 2015-06-02T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/poseida-expands-into-jlabs-to-foster-research-deal-with-janssen-for-allogeneic-car-t-therapies-020615-4591047/ 2015-06-02T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-releases-positive-phase-iii-data-of-prolia-in-breast-cancer-patients-receiving-aromatase-inhibitors-020615-4591065/ 2015-06-02T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/vitesse-biologics-formed-to-identify-early-stage-biologic-research-in-immunology-hematology-and-oncology-020615-4591078/ 2015-06-02T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/elusys-therapeutics-gets-fda-acceptance-for-bla-of-anthim-to-treat-and-preventi-inhalational-anthrax-020615-4591096/ 2015-06-02T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-to-buy-otc-drugs-portfolio-of-glaxosmithkline-030615-4591556/ 2015-06-03T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-drug-gets-nhs-approval-for-use-in-lung-cancer-treatment-030615-4591697/ 2015-06-03T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-secures-license-to-bristol-myers-antibody-panel-targeting-cd19-protein-030615-4591755/ 2015-06-03T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-intunivt-tablets-in-us-to-treat-adhd-030615-4591955/ 2015-06-03T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-status-for-lipocines-preterm-birth-prevention-drug-030615-4592012/ 2015-06-03T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-and-weill-cornell-collaborate-to-research-new-leukemia-immunotherapies-030615-4591915/ 2015-06-03T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-actavis-and-perrigos-application-for-generic-chest-congestion-tablets-030615-4591814/ 2015-06-03T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-helsinns-akynzeo-to-prevent-cinv-in-eu-030615-4592439/ 2015-06-03T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-anokion-to-collaborate-on-immune-tolerance-therapeutics-030615-4592451/ 2015-06-03T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/anis-oxycodone-hydrochloride-oral-solution-5mg5ml-gets-fda-approval-030615-4592454/ 2015-06-03T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-consolidate-us-vaccine-sites-in-bostoncambridge-area-030615-4592460/ 2015-06-03T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/north-american-pharmaceutical-market-focus-shifting-from-prescriber-to-payer-says-globaldata-030615-4592484/ 2015-06-03T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-gets-european-regulatory-guidance-for-potential-maa-for-tivozanib-040615-4593776/ 2015-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-bluebird-bio-to-develop-anti-bcma-product-candidates-040615-4593780/ 2015-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lcrf-ualc-merge-to-fight-deadliest-cancer-040615-4593781/ 2015-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biota-pharmaceuticals-closes-acquisition-of-anaconda-pharma-040615-4593783/ 2015-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/celator-completes-patient-enrollment-is-phase-ii-trial-of-cpx-351-liposome-injection-040615-4593785/ 2015-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxinnate-begins-phase-ii-trial-of-quadrivalent-seasonal-influenza-vaccine-candidate-040615-4592796/ 2015-06-04T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-and-progenics-treatment-for-opioid-induced-constipation-gets-eu-approval-040615-4592976/ 2015-06-04T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/eip-pharma-doses-first-patient-in-phase-ii-development-of-vx-745-alzheimers-drug-040615-4593011/ 2015-06-04T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/amicus-submits-maa-seeking-full-approval-for-galafold-in-eu-to-treat-fabry-040615-4593033/ 2015-06-04T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-to-develop-products-on-halozymes-enhanze-platform-040615-4592939/ 2015-06-04T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/arno-therapeutics-to-evaluate-antiviral-activity-of-ar-12-for-us-army-040615-4593109/ 2015-06-04T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/adapt-pharma-submits-rolling-nda-for-intranasal-treatment-for-opioid-overdose-040615-4593060/ 2015-06-04T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/cynapsus-secures-us-patent-for-sublingual-apomorphine-050615-4594733/ 2015-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/synageva-completes-targeted-enrollment-in-phase-12-trial-with-sbc-103-for-mps-iiib-050615-4594743/ 2015-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/palatin-supports-fdas-recommendation-to-approve-flibanserin-for-hsdd-treatment-050615-4594746/ 2015-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/parion-sciences-licenses-enac-inhibitors-to-vertex-050615-4593854/ 2015-06-05T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-gives-positive-opinion-on-dbvs-proposal-for-paediatric-viaskin-peanut-treatment-050615-4594107/ 2015-06-05T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-retrophins-re-024-to-treat-pkan-050615-4594141/ 2015-06-05T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vtv-therapeutics-begins-dosing-patients-in-phase-iib-trial-of-ttp399-to-treat-type-2-diabetes-050615-4594168/ 2015-06-05T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pivotal-therapeutics-enrols-first-patient-in-phase-iia-pomega-trial-of-pvt-100-050615-4594187/ 2015-06-05T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/casi-seeks-approval-to-begin-trial-of-flc-drug-in-china-050615-4594216/ 2015-06-05T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-panel-okays-sprouts-drug-to-cure-sexual-desire-disorder-in-women-050615-4594310/ 2015-06-05T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/rhythm-begins-two-phase-ii-trials-of-setmelanotide-in-rare-genetic-disorders-of-obesity-050615-4594384/ 2015-06-05T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/moffitt-cancer-center-doses-first-patient-in-kite-pharmas-phase-iii-of-kte-c19-for-nhl-050615-4594393/ 2015-06-05T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/shires-resolor-gets-european-approval-for-treatment-of-chronic-constipation-080615-4594239/ 2015-06-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-asthma-inhaler-sirdupla-to-uk-markets-4595245/ 2015-06-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-begins-rolling-submission-of-daratumumab-for-treatment-of-multiple-myeloma-080615-4595253/ 2015-06-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mountain-river-physical-therapy-selects-clinicients-practice-insight-080615-4596471/ 2015-06-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oculus-receives-fda-clearance-for-novel-atopic-dermatitis-dermatology-product-080615-4597200/ 2015-06-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-health-plans-to-buy-harvard-drug-group-for-112bn-4594887/ 2015-06-08T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/complete-genomics-exhibits-its-new-sequencing-system-at-european-human-genetics-conference-080615-4595064/ 2015-06-08T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-presents-positive-data-from-bil-phase-iii-clinical-trial-program-080615-4595263/ 2015-06-08T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/india-and-netherlands-sign-mou-to-develop-vaccines-080615-4595751/ 2015-06-08T09:22:00+00:00 https://www.pharmaceutical-business-review.com/news/aethon-to-introduce-traysafe-next-generation-automated-kit-replenishment-and-logistics-solution-080615-4595752/ 2015-06-08T09:28:00+00:00 https://www.pharmaceutical-business-review.com/news/sec-charges-ardea-biosciences-employee-two-stockbrokers-with-insider-trading-090615-4597039/ 2015-06-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-announces-collaboration-with-nationwide-laboratories-090615-4597175/ 2015-06-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/therapeuticsmd-completes-patient-recruitment-in-rejoice-trial-of-tx-004hr-090615-4597194/ 2015-06-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pozen-to-acquire-tribute-pharmaceuticals-canada-for-146m-090615-4596007/ 2015-06-09T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/glukos-delivers-first-production-batch-of-its-fruit-punch-tablets-090615-4596267/ 2015-06-09T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-md-anderson-cancer-center-to-enhance-development-of-intratumoral-tlr9-agonist-090615-4596341/ 2015-06-09T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/convergence-point-media-opens-ehealthstore-for-ready-to-buy-health-consumers-090615-4596432/ 2015-06-09T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-teams-up-with-llumina-and-genea-to-form-global-fertility-alliance-090615-4596428/ 2015-06-09T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/tillotts-and-numab-partner-for-tnf-alpha-blockers-for-inflammatory-bowel-090615-4596480/ 2015-06-09T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/medicines-for-psoriasis-and-hepatitis-c-accepted-for-use-in-scotland-by-smc-090615-4596727/ 2015-06-09T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/advantar-labs-opens-new-non-sterile-manufacturing-facility-090615-4596736/ 2015-06-09T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/germanys-amp-biosimilars-out-licensed-second-biosimilar-product-aby-021-to-chinese-firm-100615-4597054/ 2015-06-10T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fdas-emdac-recommends-approval-of-sanofi-and-regenerons-alirocumab-100615-4597068/ 2015-06-10T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/symbiomix-begins-dosing-in-phase-3-trial-of-sym-1219-to-treat-bacterial-vaginosis-100615-4597393/ 2015-06-10T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-clearance-for-angion-to-begin-phase-ii-trial-of-bb3-in-aki-100615-4597354/ 2015-06-10T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-mgh-to-evaluate-tesamorelin-to-treat-liver-disease-in-hiv-patients-100615-4597439/ 2015-06-10T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-awards-17m-grant-to-advance-exosome-based-cancer-drug-technology-100615-4597477/ 2015-06-10T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/lycera-celgene-partner-to-advance-new-immune-modulators-100615-4597523/ 2015-06-10T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/apitope-gets-fda-orphan-drug-status-for-atx-f8-117-to-treat-haemophilia-a-patients-100615-4597547/ 2015-06-10T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/new-bill-unveiled-to-make-birth-control-pills-available-without-prescription-in-us-100615-4597603/ 2015-06-10T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-biomedicine-enters-into-definitive-agreement-to-acquire-cd40lgvax-vaccine-100615-4597834/ 2015-06-10T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/cytodyn-cleared-by-fda-to-start-phase-iii-trial-of-first-injectable-antibody-for-hiv-100615-4597819/ 2015-06-10T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/mission-pharmacal-acquires-prosolus-pharmaceuticals-100615-4597825/ 2015-06-10T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-epic-pharma-enter-into-licensing-deal-for-abuse-deterrent-eli-200-100615-4597810/ 2015-06-10T08:59:00+00:00 https://www.pharmaceutical-business-review.com/news/goodwin-aspyrian-collaborate-on-successful-gmp-manufacturing-ind-submission-for-new-adc-platform-100615-4597814/ 2015-06-10T09:01:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-europe-introduces-in-house-developed-thyroid-cancer-drug-lenvima-in-uk-110615-4598143/ 2015-06-11T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-gets-fda-breakthrough-therapy-for-actemraroactemra-to-teat-systemic-sclerosis-110615-4598203/ 2015-06-11T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-gets-fda-orphan-drug-status-for-ag-120-to-treat-acute-myelogenous-leukemia-110615-4598514/ 2015-06-11T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-arrowheads-arc-aat-to-treat-liver-disease-110615-4598538/ 2015-06-11T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bergenbio-begins-phase-ib-nsclc-trial-of-bgb324-in-combination-with-erlotinib-110615-4598564/ 2015-06-11T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/relmada-completes-phase-i-trial-of-d-methadone-to-treat-neuropathic-pain-110615-4598592/ 2015-06-11T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ziarco-begins-phase-iia-trial-of-zpl-389-to-treat-atopic-dermatitis-110615-4598694/ 2015-06-11T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-pharma-expands-immuno-dermatology-development-portfolio-110615-4598952/ 2015-06-11T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/intrexon-oragenics-to-pursue-development-of-biotherapeutics-for-oral-cavity-110615-4598953/ 2015-06-11T09:25:00+00:00 https://www.pharmaceutical-business-review.com/news/selecta-begins-phase-i-clinical-program-of-sel-212-to-treat-gout-110615-4598956/ 2015-06-11T09:28:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-expands-european-and-canadian-patent-protection-of-smarticles-nucleic-acid-delivery-technology-110615-4598959/ 2015-06-11T09:32:00+00:00 https://www.pharmaceutical-business-review.com/news/melior-gets-patent-approval-from-uspto-for-new-parkinsons-disease-drug-candidate-110615-4598960/ 2015-06-11T09:35:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-promacta-gets-fda-approval-to-treat-pediatric-patients-with-chronic-itp-120615-4599174/ 2015-06-12T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-begins-second-phase-iii-trial-of-epidiolexto-treat-lennox-gastaut-syndrome-120615-4599250/ 2015-06-12T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-macrophage-to-engineer-cd206-accurin-nanoparticle-using-manocept-targeting-platform-120615-4599334/ 2015-06-12T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-phase-iii-trial-of-pristiq-in-mdd-patients-fails-to-meet-primary-objective-120615-4599367/ 2015-06-12T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/adamas-initiates-phase-ii-trial-of-ads-5102-to-treat-ms-patients-with-walking-impairment-120615-4599511/ 2015-06-12T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/arcturus-janssen-to-develop-rna-medicines-for-specified-diseases-120615-4599529/ 2015-06-12T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-glaxosmithklines-asthma-drug-mepolizumab-for-adults-120615-4599602/ 2015-06-12T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-collaborates-with-global-fund-to-increase-access-to-affordable-infectious-disease-testing-in-low-and-middle-income-countries-120615-4600022/ 2015-06-12T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/tioga-pharmaceuticals-begins-phase-ii-trial-of-asimadoline-in-patients-with-pruritus-associated-with-atopic-dermatitis-160615-4600017/ 2015-06-12T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/forum-pharmaceuticals-completes-patient-enrollment-in-phase-iii-trial-program-of-encenicline-for-cognitive-impairment-in-schizophrenia-120615-4600015/ 2015-06-12T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/mpp-gilead-expand-licence-to-allow-generic-manufacture-of-medicines-in-south-africa-120615-4600012/ 2015-06-12T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-vision-completes-nda-submission-to-us-fda-for-bromsite-120615-4600018/ 2015-06-12T08:52:00+00:00 https://www.pharmaceutical-business-review.com/news/seres-ser-109-gets-fda-breakthrough-therapy-status-to-prevent-cdi-in-adults-150615-4600210/ 2015-06-15T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-reports-positive-phase-ib-trial-results-of-venetoclax-with-rituximab-in-cll-patients-150615-4600532/ 2015-06-15T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gensco-enters-into-research-collaboration-with-oa-centers-of-america-150615-4600567/ 2015-06-15T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-begins-dosing-in-second-phase-iia-trial-of-syn-004-150615-4600484/ 2015-06-15T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-corbus-resunab-to-treat-systemic-sclerosis-150615-4600552/ 2015-06-15T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/grnenthal-boston-childrens-hospital-and-proteus-to-develop-neosaxitoxin-for-pain-management-150615-4600599/ 2015-06-15T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/medicinova-completes-patient-enrolment-in-phase-iib-trial-of-mn-166-to-treat-progressive-ms-150615-4600642/ 2015-06-15T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/mei-pharma-reports-updated-phase-ii-trial-results-of-pracinostat-and-azacitidine-in-elderly-aml-patients-150615-4600938/ 2015-06-15T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/regen-gets-notice-of-allowance-for-us-patent-for-screening-of-small-molecules-against-nuclear-receptor-target-150615-4600946/ 2015-06-15T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/reaction-biology-gets-nih-grant-for-bromodomain-research-150615-4600953/ 2015-06-15T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/independent-study-finds-iv-vernakalant-helps-ecv-in-patients-with-cardioversion-resistant-af-150615-4600959/ 2015-06-15T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-biopharma-baxter-report-positive-results-from-phase-iii-trial-of-pacritinib-in-patients-with-myelofibrosis-150615-4600970/ 2015-06-15T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-begins-phase-iii-trial-of-olipudase-alfa-to-treat-asmd-in-pediatric-patients-160615-4601239/ 2015-06-16T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-tevas-bla-for-asthma-drug-reslizumab-160615-4601338/ 2015-06-16T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/agalimmune-licenses-kodes-fsl-technology-for-new-cancer-immunotherapies-160615-4601611/ 2015-06-16T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-submits-spa-request-to-fda-for-phase-iii-trial-of-adxs-hpv-in-cervical-cancer-160615-4601654/ 2015-06-16T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/nutrinias-ntra-9620-gets-fda-orphan-status-to-treat-short-bowel-syndrome-160615-4601686/ 2015-06-16T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-expand-caltrate-and-centrum-production-in-china-with-new-95m-production-plant-160615-4601713/ 2015-06-16T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampos-ind-for-pivotal-study-of-constipation-drug-amitiza-gets-china-fda-acceptance-160615-4601749/ 2015-06-16T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/heavy-hydrogen-in-living-organisms-may-provide-clues-to-prevent-and-treat-cancer-160615-4602012/ 2015-06-16T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/plasmatech-adds-another-aav-gene-therapy-program-to-product-pipeline-160615-4602032/ 2015-06-16T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-enters-into-manufacturing-agreement-with-pct-for-us-production-of-ict-107-160615-4602038/ 2015-06-16T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/avalanche-reports-positive-top-line-phase-iia-results-for-ava-101-in-wet-amd-160615-4602041/ 2015-06-16T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/praxsyn-executes-new-services-agreement-with-nhs-pharma-160615-4602048/ 2015-06-16T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-johns-hopkins-partner-to-develop-new-ophthalmic-therapies-170615-4602403/ 2015-06-17T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/west-pharmaceutical-begins-construction-of-new-manufacturing-facility-in-ireland-170615-4602610/ 2015-06-17T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/heron-begins-phase-ii-trial-of-htx-011-to-treat-post-operative-pain-170615-4602656/ 2015-06-17T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/ocular-enrolls-first-patient-in-phase-iii-trial-of-dextenza-to-treat-allergic-conjunctivitis-170615-4602687/ 2015-06-17T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-status-for-protalexs-prtx-100-to-treat-immune-thrombocytopenia-170615-4602731/ 2015-06-17T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/gat-introduces-new-formulations-for-jetfuel-superburn-and-t-300-products-170615-4602820/ 2015-06-17T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/goodbelly-intorduces-new-digestive-supplements-170615-4602834/ 2015-06-17T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/startup-nutraceutical-wellness-launches-maiden-hair-health-product-170615-4602841/ 2015-06-17T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/genticel-gets-fda-nod-to-begin-us-phase-i-trial-of-hpv-therapeutic-vaccine-candidate-gtl001-170615-4602782/ 2015-06-17T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/pulmatrix-mylan-to-jointly-develop-pur0200-for-copd-170615-4602804/ 2015-06-17T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-pharma-gets-new-patent-for-abuse-deterrent-technology-170615-4603257/ 2015-06-17T09:21:00+00:00 https://www.pharmaceutical-business-review.com/news/xoma-gets-fda-orphan-status-for-xoma-358-to-treat-congenital-hyperinsulinism-170615-4603260/ 2015-06-17T09:24:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-agrees-to-buy-kythera-for-21bn-180615-4603255/ 2015-06-17T09:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-biondvaxs-ind-application-for-investigational-universal-flu-vaccine-180615-4603550/ 2015-06-18T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-inserm-to-investigate-new-therapies-for-type-2-diabetes-and-ckd-180615-4603752/ 2015-06-18T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-scri-to-jointly-develop-new-investigational-oncology-therapy-180615-4603695/ 2015-06-18T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/jcr-sumitomo-to-develop-new-treatments-for-psychiatric-and-neurological-disorders-180615-4603675/ 2015-06-18T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/biocsl-secures-worldwide-rights-to-commercialize-biocryst-influenza-treatment-rapivab-180615-4603772/ 2015-06-18T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/impaxs-zomig-nasal-spray-gets-fda-approval-to-treat-migraine-in-pediatric-patients-180615-4603800/ 2015-06-18T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/akaal-pharma-gets-approval-to-begin-phase-ii-trial-of-akp-11-to-treat-psoriasis-180615-4603851/ 2015-06-18T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-create-independent-research-institute-to-change-and-improve-medicines-development-180615-4603860/ 2015-06-18T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/hemostemix-lbi-to-explore-applications-of-hemostemix-technology-for-restoring-blood-supply-180615-4603867/ 2015-06-18T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-begins-phase-iii-trial-of-cat-1004-to-treat-duchenne-muscular-dystrophy-180615-4603873/ 2015-06-18T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/atopix-gets-funding-to-broaden-development-of-crth2-antagonists-for-th2-mediated-disease-180615-4603885/ 2015-06-18T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/akashi-reports-positive-clinical-data-on-ht-100-in-dmd-patients-190615-4605464/ 2015-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-phase-iii-trial-results-of-cancer-drug-vectibix-190615-4605467/ 2015-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cellresearch-gets-new-us-patent-approval-for-exclusive-stem-cell-technology-amidst-new-partnerships-190615-4605475/ 2015-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/emulate-janssen-partner-to-use-organs-on-chips-platform-to-predict-human-response-in-drug-development-process-190615-4605478/ 2015-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-completes-patient-enrollment-in-phase-ii-origin-trial-of-glpg1205-to-treat-ulcerative-colitis-190615-4605481/ 2015-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-begins-hokusai-vte-cancer-study-of-edoxaban-in-vte-patients-4604649/ 2015-06-19T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/hemostemix-prepares-ind-application-for-acp-01-to-treat-critical-limb-ischemia-190615-4604853/ 2015-06-19T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/momenta-sandoz-introduce-glatopa-injection-in-us-190615-4604875/ 2015-06-19T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-status-for-aimmunes-ar101-to-treat-peanut-allergy-190615-4604921/ 2015-06-19T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-grants-approval-for-stemcells-phase-ii-trial-for-cervical-spinal-cord-injury-190615-4604936/ 2015-06-19T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/caladrius-collaborates-with-two-us-universities-for-new-core-cancer-technology-strategies-190615-4605004/ 2015-06-19T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-seeks-more-information-for-gileads-leukemia-drug-idelalisib-220615-4604973/ 2015-06-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-reports-positive-data-from-phase-i-trial-of-tazemetostat-to-treat-non-hodgkin-lymphoma-220615-4606353/ 2015-06-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medday-reports-additional-positive-data-from-phase-iii-trial-of-md1003-to-treat-progressive-multiple-sclerosis-220615-4606368/ 2015-06-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ophthalix-signs-definitive-agreement-to-acquire-improved-vision-systems-220615-4606379/ 2015-06-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-oncology-research-cure-forward-to-advance-clinical-research-and-precision-medicine-together-220615-4606381/ 2015-06-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sdc-nutrition-continues-to-expand-global-presence-with-growth-into-brazil-220615-4606386/ 2015-06-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myerss-melanoma-drug-opdivo-gets-approval-in-europe-220615-4605706/ 2015-06-22T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/admune-begins-patient-enrolment-in-phase-i-trial-of-hetil-15-to-treat-metastatic-cancers-220615-4605965/ 2015-06-22T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cdc-foundation-pfizer-and-cdc-to-develop-longitudinal-data-collection-system-for-scd-220615-4606043/ 2015-06-22T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-beigenes-ind-for-bgb-3111-to-treat-b-cell-malignancies-220615-4606073/ 2015-06-22T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/aop-orphan-seeks-approval-for-tetrabenazine-in-european-countries-for-tardive-dyskinesia-220615-4605935/ 2015-06-22T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/ontario-invests-25m-in-oirm-for-stem-cell-research-220615-4606005/ 2015-06-22T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-results-from-phase-ii-trial-of-amg-334-to-prevent-migraine-220615-4606098/ 2015-06-22T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-agrees-to-buy-gsks-two-meningitis-vaccines-for-130m-230615-4606635/ 2015-06-23T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/benitec-reneuron-extend-research-collaboration-to-develop-cellular-therapies-230615-4606946/ 2015-06-23T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-forums-encenicline-to-treat-cognitive-impairment-in-schizophrenia-230615-4606985/ 2015-06-23T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-bluebird-bio-to-jointly-advance-second-generation-tcr-cell-therapy-products-230615-4606962/ 2015-06-23T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-medicines-companys-kengreal-as-adjunct-to-pci-for-reducing-thrombotic-events-230615-4607017/ 2015-06-23T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-begins-patient-enrollment-for-thirteenth-group-in-polish-phase-iii-trial-of-l-dos47-to-treat-lung-cancer-230615-4607061/ 2015-06-23T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/amphastar-gets-fda-approval-for-amphadase-to-improve-resorption-of-radiopaque-agents-230615-4607083/ 2015-06-23T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/vical-reports-top-line-results-from-phase-12-trial-of-therapeutic-genital-herpes-vaccine-230615-4607424/ 2015-06-23T09:15:00+00:00 https://www.pharmaceutical-business-review.com/news/invivo-gets-notice-of-allowance-on-patent-covering-broader-compositions-to-treat-open-and-closed-wound-spinal-cord-injuries-230615-4607435/ 2015-06-23T09:18:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-reports-additional-statistically-significant-study-results-for-optina-to-treat-dme-230615-4607418/ 2015-06-23T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/ims-health-fmi-to-optimize-targeting-of-precision-therapies-in-oncology-230615-4607431/ 2015-06-23T09:38:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxils-immucin-gets-fda-orphan-drug-status-to-treat-multiple-myeloma-230615-4607416/ 2015-06-23T09:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-gets-fda-authorization-of-first-in-human-trial-with-astrazenecas-accurin-azd2811-240615-4608923/ 2015-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-selects-next-generation-of-merchandising-from-galleria-240615-4608928/ 2015-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eisais-fycompa-to-treat-primary-generalized-tonic-clonic-seizures-240615-4608930/ 2015-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-begins-patient-enrollment-in-phase-iii-trial-of-rivipansel-to-treat-vaso-occlusive-crisis-240615-4607696/ 2015-06-24T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/paratek-begins-dosing-in-phase-iii-trial-of-omadacycline-to-treat-absssi-240615-4608048/ 2015-06-24T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-submits-nda-to-us-fda-for-oral-relistor-to-treat-oic-in-adults-with-chronic-non-cancer-pain-240615-4608113/ 2015-06-24T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/avexis-gene-therapy-treatment-for-spinal-muscular-atrophy-gets-ema-orphan-drug-status-240615-4608081/ 2015-06-24T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/etubics-nci-partner-to-further-develop-therapeutic-cancer-vaccines-240615-4608141/ 2015-06-24T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/wockhardt-gets-anda-approval-from-fda-for-pain-medication-oxycodone-liquid-240615-4608163/ 2015-06-24T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/aobiome-begins-phase-ii-trial-of-aob-based-therapeutic-for-acne-vulgaris-240615-4608188/ 2015-06-24T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-expands-production-of-nyloxin-240615-4608310/ 2015-06-24T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-will-win-big-with-melanoma-combination-immunotherapy-globaldata-240615-4608408/ 2015-06-24T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-begins-dosing-in-phase-i-trial-of-ag-881-in-patients-with-advanced-solid-tumors-with-idh-250615-4608788/ 2015-06-25T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/obseva-begins-enrollment-in-phase-ii-term-trial-of-obe001-in-pregnant-women-with-preterm-labor-250615-4608933/ 2015-06-25T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/jcr-pharmaceuticals-selects-medidatas-cloud-based-platform-for-to-rare-disease-clinical-research-in-japan-250615-4608936/ 2015-06-25T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/columbia-care-enters-into-agreement-with-mount-sinai-to-drive-medical-marijuana-research-250615-4608944/ 2015-06-25T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/celator-reports-positive-induction-response-results-from-phase-iii-trial-of-cpx-351-in-aml-patients-250615-4608957/ 2015-06-25T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/cdc-advisory-committee-votes-to-recommend-pfizers-serogroup-b-meningococcal-disease-vaccination-250615-4609150/ 2015-06-25T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-reports-positive-phase-iiib-results-of-viekirax-exviera-in-hcv-patients-250615-4609059/ 2015-06-25T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-maruishi-to-commercialize-remifentanil-injection-generic-250615-4609091/ 2015-06-25T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/vaccinex-starts-phase-ii-trial-of-vx152503-antibody-to-treat-huntingtons-disease-250615-4609114/ 2015-06-25T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-completes-takeover-of-synageva-250615-4609179/ 2015-06-25T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/tokai-initiates-phase-iii-galeterone-trial-in-patients-with-ar-v7-positive-mcrpc-250615-4609227/ 2015-06-25T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-expands-rd-presence-with-new-research-site-in-cambridge-us-260615-4610771/ 2015-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aquinox-releases-positive-results-from-phase-ii-trial-with-aqx-1125-to-treat-bpsic-260615-4610776/ 2015-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pbm-capital-invests-in-xalud-therapeutics-gene-therapy-platform-to-treat-neuro-inflammatory-diseases-260615-4610783/ 2015-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/stealth-biotherapeutics-reports-results-from-review-study-of-ocuvia-in-dme-patients-260615-4610763/ 2015-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/protein-sciences-reports-positive-results-from-new-clinical-study-of-flublok-influenza-vaccine-260615-4610767/ 2015-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/siemens-biontech-to-develop-new-personalized-cancer-vaccines-260615-4609826/ 2015-06-26T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/novasep-strengthens-bio-conjugation-services-with-new-adc-facility-in-france-260615-4609958/ 2015-06-26T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-begins-two-phase-ii-trials-with-bertilimumab-to-treat-ulcerative-colitis-and-bullous-pemphigoid-260615-4610194/ 2015-06-26T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-incyte-to-evaluate-new-immunotherapy-combination-to-treat-platinum-sensitive-ovarian-cancer-260615-4610212/ 2015-06-26T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-amicus-maa-for-galafold-to-treat-fabry-patients-260615-4610237/ 2015-06-26T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinion-for-newrons-sarizotan-to-treat-rett-syndrome-260615-4610261/ 2015-06-26T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/niaaa-begins-clinical-study-of-gabapentin-enacarbil-to-treat-patients-with-aud-260615-4610280/ 2015-06-26T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-approval-of-novartiss-multiple-myeloma-drug-farydak-290615-4610875/ 2015-06-29T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-to-secure-eurostars-grant-of-eur09m-290615-4610976/ 2015-06-29T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-grants-positive-opinion-for-abbvies-humira-to-treat-hidradenitis-suppurativa-290615-4611334/ 2015-06-29T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-eylea-gets-approval-in-japan-to-treat-retinal-vein-occlusion-290615-4611361/ 2015-06-29T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinions-for-alexions-strensiq-and-kanuma-290615-4611404/ 2015-06-29T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-biogen-and-sobis-maa-for-alprolix-to-treat-hemophilia-b-290615-4611429/ 2015-06-29T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-exercises-3m-in-additional-contract-funding-to-develop-aeolus-aeol-10150-to-treat-acute-radiation-syndrome-290615-4611580/ 2015-06-29T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-gets-large-investment-from-asian-equity-firm-290615-4611585/ 2015-06-29T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/pro-bono-bio-gets-15m-to-accelerate-the-global-launches-of-flexiseq-and-sequaderma-290615-4611592/ 2015-06-29T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/proqr-begins-patient-enrollment-in-phase-ib-trial-of-qr-010-to-treat-cystic-fibrosis-290615-4611560/ 2015-06-29T09:14:00+00:00 https://www.pharmaceutical-business-review.com/news/spyryx-gets-development-award-to-advance-novel-therapy-for-cystic-fibrosis-290615-4611448/ 2015-06-29T09:15:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-agrees-to-buy-spinifex-pharmaceuticals-for-over-200m-300615-4611851/ 2015-06-30T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/cosmederm-bioscience-introduces-two-new-steroid-free-itch-relief-products-300615-4612252/ 2015-06-30T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-juno-to-develop-new-immunotherapies-for-cancer-and-autoimmune-diseases-300615-4612174/ 2015-06-30T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-launches-pain-drug-tivorbex-in-us-300615-4612284/ 2015-06-30T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/steadymed-cardiome-partner-to-commercialize-pah-drug-trevyent-outside-us-300615-4612193/ 2015-06-30T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-commercialize-tris-dextromethorphan-cough-syrup-under-robitussin-brand-300615-4612219/ 2015-06-30T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-makes-changes-to-to-kerydin-commercialization-agreement-300615-4612352/ 2015-06-30T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/bsn-medical-expand-lymphoedema-therapy-solutions-with-farrowmed-acquisition-300615-4612360/ 2015-06-30T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bioblast-gets-orphan-drug-status-for-cabaletta-in-europe-to-teat-spinocerebellar-ataxia-300615-4612373/ 2015-06-30T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/vitae-starts-phase-i-single-ascending-dose-study-of-vtp-43742-in-autoimmune-disorders-300615-4612383/ 2015-06-30T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocore-enters-into-immunotherapy-based-clinical-trial-collaboration-with-lilly-300615-4612157/ 2015-06-30T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrogen-receives-120m-license-payment-from-astrazeneca-300615-4612391/ 2015-06-30T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/taisho-to-develop-and-commercialize-ablynxs-rheumatoid-arthritis-drug-ozoralizumab-in-japan-010715-4612883/ 2015-07-01T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-begins-patient-enrollment-in-phase-iib-oral-insulin-trial-of-ormd-0801-010715-4613144/ 2015-07-01T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neothetics-to-evaluate-clinical-effect-of-lipo-202-to-reduce-central-abdominal-bulging-010715-4613169/ 2015-07-01T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/aridis-gets-fda-fast-track-status-for-pneumonia-drug-aerucin-010715-4613188/ 2015-07-01T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/eolas-astrazeneca-to-develop-orexin-1-receptor-antagonist-to-treat-multiple-indications-010715-4613201/ 2015-07-01T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-gets-marketing-authorization-for-vibativ-in-russia-to-treat-gram-positive-bacterial-infections-010715-4613277/ 2015-07-01T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-pharma-inks-license-and-research-deal-with-yissum-for-amiket-nano-010715-4613319/ 2015-07-01T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-pharma-agrees-to-acquire-cord-blood-registry-for-700m-010715-4613309/ 2015-07-01T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-begins-phase-i-trial-with-dpx-rsv-vaccine-010715-4613327/ 2015-07-01T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-biomedicine-completes-acquisition-of-cd40lgvax-vaccine-010715-4613335/ 2015-07-01T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/medical-marijuana-holds-investment-in-axim-biotechnologies-010715-4613341/ 2015-07-01T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-selects-pickwick-capital-partners-for-strategic-advisory-services-010715-4613361/ 2015-07-01T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-stop-distribution-of-diabetes-drug-tresiba-in-germany-020715-4613942/ 2015-07-02T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-and-nih-grant-clearance-for-vistagen-to-initiate-av-101-phase-ii-mdd-trial-020715-4614223/ 2015-07-02T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-files-ind-application-with-fda-for-de-122-to-treat-wet-amd-020715-4614288/ 2015-07-02T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-submits-nda-to-fda-for-single-tablet-regimen-rftaf-to-treat-hiv-020715-4614335/ 2015-07-02T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/geovax-secures-nih-grant-for-hiv-vaccine-program-020715-4614366/ 2015-07-02T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-spriasos-nda-for-codeine-antitussive-with-anti-histamine-020715-4614393/ 2015-07-02T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-gets-two-notice-of-allowance-from-uspto-covering-rhb-104-020715-4614417/ 2015-07-02T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-gets-final-anda-approval-for-desvenlafaxine-xr-tablets-020715-4614649/ 2015-07-02T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/r-japan-secures-autologous-stem-cell-manufacturing-license-020715-4614655/ 2015-07-02T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/medicines-patent-pool-expands-generic-manufacturing-network-to-ramp-pp-low-cost-arvs-production-020715-4614664/ 2015-07-02T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/panther-biotechnology-agrees-to-buy-alchemia-oncology-020715-4614671/ 2015-07-02T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/clovis-begins-rolling-nda-submission-to-fda-for-rociletinib-to-treat-advanced-egfr-mutant-nsclc-020715-4614694/ 2015-07-02T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-generic-aggrenox-capsules-in-us-030715-4614893/ 2015-07-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tes-pharma-and-epfl-establish-rd-collaboration-030715-4614895/ 2015-07-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-and-agtc-join-forces-to-develop-gene-therapies-in-ophthalmology-030715-4614896/ 2015-07-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-join-forces-with-leukemia-lymphoma-society-030715-4614900/ 2015-07-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-spiolto-respimat-approved-in-european-countries-to-treat-copd-030715-4614901/ 2015-07-02T23:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-pfizers-nda-for-rheumatoid-arthritis-drug-xeljanz-030715-4614914/ 2015-07-02T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-gets-fda-acceptance-for-ind-application-for-mage-a10-t-in-nsclc-patients-030715-4614937/ 2015-07-03T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-begins-dosing-patients-in-phase-i-trial-of-arc-aat-to-treat-aatd-030715-4614956/ 2015-07-03T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/gileads-harvoni-gets-japanese-approval-to-treat-genotype-1-chronic-hepatitis-c-060715-4615477/ 2015-07-06T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-pharmaceuticals-acquires-russias-biocom-060715-4615731/ 2015-07-06T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/vertexs-orkambi-gets-fda-approval-to-treat-underlying-cause-of-cf-060715-4615834/ 2015-07-06T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-galdermas-restylane-lyft-with-lidocaine-for-age-related-volume-loss-in-cheek-area-060715-4615799/ 2015-07-06T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/viventia-starts-recruitment-of-clinical-centers-for-phase-iii-bladder-cancer-trial-of-vicinium-060715-4615867/ 2015-07-06T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/cyclacel-begins-dosing-in-investigator-sponsored-trial-of-seliciclib-to-treat-cushings-disease-060715-4615893/ 2015-07-06T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/glycotope-cantargia-sign-production-agreement-for-monoclonal-antibody-can04-060715-4615913/ 2015-07-06T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/avexxin-completes-phase-iiia-trial-of-avx001-in-psoriasis-060715-4616315/ 2015-07-06T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/adapt-pharma-acquires-narcan-nda-secures-license-to-narcan-trademark-060415-4616313/ 2015-07-06T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/milestone-led-consortium-gets-42m-to-develop-stem-cell-medium-and-tnstrument-to-treat-diabetes-060715-4616311/ 2015-07-06T09:25:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-desano-enter-manufacturing-agreement-for-dolutegravir-in-china-060715-4616308/ 2015-07-06T09:27:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-to-acquire-depomed-for-3bn-070715-4619353/ 2015-07-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-health-acquires-harvard-drug-group-for-112bn-070715-4616611/ 2015-07-07T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/alexions-strensiq-gets-approval-in-japan-to-treat-hypophosphatasia-070715-4616841/ 2015-07-07T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-novella-to-conduct-phase-iii-registration-trial-of-ict-107-to-treat-glioblastoma-070715-4616874/ 2015-07-07T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/evofem-files-nda-to-fda-for-amphora-as-contraceptive-070715-4616896/ 2015-07-07T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/celtaxsys-gets-fda-nod-to-begin-phase-ii-trial-of-acebilustat-to-treat-cystic-fibrosis-070715-4616926/ 2015-07-07T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-catabasis-cat-1004-to-treat-duchenne-muscular-dystrophy-070715-4616947/ 2015-07-07T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-treats-first-iatient-in-phase-iii-trial-of-antibody-therapy-to-treat-staphylococcus-aureus-infections-070715-4616972/ 2015-07-07T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/akcea-gets-fda-orphan-drug-status-for-volanesorsen-to-treat-familial-chylomicronemia-syndrome-070715-4617346/ 2015-07-07T09:37:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-secures-authorization-in-australia-and-new-zealand-for-ongoing-phase-iii-crohns-disease-trial-with-rhb-104-070715-4617350/ 2015-07-07T09:39:00+00:00 https://www.pharmaceutical-business-review.com/news/ignyta-collaborates-with-ucsf-for-clinical-trial-of-entrectinib-070715-4617353/ 2015-07-07T09:40:00+00:00 https://www.pharmaceutical-business-review.com/news/resverlogix-closes-license-deal-and-enters-definitive-stock-purchase-agreement-with-hepalink-080715-4619303/ 2015-07-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-enrolls-first-patient-in-phase-iib-trial-of-staphylococcus-aureus-vaccine-080715-4617510/ 2015-07-08T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharma-agrees-to-buy-innovatives-brand-of-diet-aids-080715-4617918/ 2015-07-08T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-agrees-to-buy-mercks-two-migraine-drugs-080715-4617654/ 2015-07-08T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/cognizin-citicoline-shows-promise-in-bipolar-patients-with-cocaine-dependence-080715-4617935/ 2015-07-08T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/sernova-massachusetts-general-hospital-to-develop-new-diabetes-treatment-with-funding-support-from-jdrf-080715-4617932/ 2015-07-08T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fierce-nutritionals-introduces-north-american-product-line-080715-4617938/ 2015-07-08T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-enters-oncology-research-collaboration-with-vanderbilt-university-medical-center-080715-4618031/ 2015-07-08T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/abide-begins-dosing-in-phase-ia-trial-of-endocannabinoid-system-modulator-abx-1431-080715-4618055/ 2015-07-08T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/nemus-mississippi-university-to-develop-proprietary-cannabidiol-molecules-080715-4618067/ 2015-07-08T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-status-for-dyaxs-dx-2930-to-prevent-hae-attacks-080715-4618085/ 2015-07-08T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/vandas-hetlioz-approved-in-eu-to-treat-non-24-hour-sleep-wake-disorder-in-totally-blind-people-080715-4618110/ 2015-07-08T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-cti-jeffrey-modell-foundation-to-develop-new-drugs-for-immunological-diseases-090715-4618636/ 2015-07-09T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-gets-clearance-to-begin-part-b-of-phase-i-arc-aat-trial-in-uk-and-new-zealand-090715-4619004/ 2015-07-09T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-protein-sciences-201516-formulation-of-flublok-influenza-vaccine-090715-4618979/ 2015-07-09T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-gets-undisclosed-milestone-payment-in-servier-collaboration-090715-4619043/ 2015-07-09T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-pharmathene-to-develop-anthrax-vaccine-formulated-in-depovax-090715-4619098/ 2015-07-09T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/akorn-introduces-acetylcysteine-injection-in-us-090715-4619129/ 2015-07-09T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novartiss-heart-failure-drug-entresto-090715-4619156/ 2015-07-09T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/pieris-to-secure-seventh-milestone-payment-from-daiichi-sankyo-collaboration-to-develop-anticalin-therapeutics-090715-4619318/ 2015-07-09T09:50:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-pharmaceuticals-amends-pain-licensing-agreement-090715-4619309/ 2015-07-09T09:52:00+00:00 https://www.pharmaceutical-business-review.com/news/tillotts-to-buy-non-us-rights-of-astrazenecas-gastroenterology-drug-entocort-for-250m-100715-4619734/ 2015-07-10T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-completes-rolling-submission-of-bla-to-fda-for-multiple-myeloma-drug-daratumumab-100715-4619785/ 2015-07-10T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-lymphoma-drug-bexarotene-75mg-100715-4619873/ 2015-07-10T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-japan-sumitomo-sign-sales-collaboration-for-trulicity-100715-4619877/ 2015-07-10T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/igi-laboratories-launches-pain-treatment-diclofenac-sodium-15-100715-4620056/ 2015-07-10T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/monopar-cancer-research-uk-partner-for-new-oncology-compound-100715-4620116/ 2015-07-10T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/adamas-completes-recruitment-in-phase-iii-ease-lid-trial-evaluating-ads-5102-100715-4620494/ 2015-07-10T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/nanotherapeutics-gets-barda-ffmn-task-orders-to-develop-two-fda-drug-shortage-products-100715-4620505/ 2015-07-10T08:59:00+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-extends-celgene-research-collaboration-100715-4620509/ 2015-07-10T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-acquires-sports-one-adding-to-premier-line-up-of-sports-nutrition-brands-100715-4620500/ 2015-07-10T09:09:00+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-company-authorizes-generic-launch-of-angiomax-100715-4620497/ 2015-07-10T09:13:00+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-begins-dosing-in-phase-ii-trial-for-tazemetostat-to-treat-relapsed-or-refractory-nhl-100715-4620086/ 2015-07-10T09:34:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-imbruvica-gets-approval-in-europe-to-treat-waldenstroms-macroglobulinemia-130715-4620821/ 2015-07-13T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-veloxis-envarsus-to-treat-kidney-transplant-patients-130715-4621157/ 2015-07-13T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-reports-results-from-first-phase-iiia-trial-of-type-2-diabetes-drug-semaglutide-130715-4621109/ 2015-07-13T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-closes-patient-enrolment-in-phase-iii-trial-of-hgh-ctp-in-ghd-adults-130715-4621195/ 2015-07-13T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/apceth-cologne-university-to-develop-combination-cellular-immunotherapies-for-cancer-130715-4621242/ 2015-07-13T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-begins-phase-ii-trial-of-adcetris-to-treat-lupus-130715-4621267/ 2015-07-13T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/symplmed-introduces-hypertension-drug-prestalia-in-us-130715-4621517/ 2015-07-13T09:21:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-pharmatechs-subsidiary-sta-enters-into-private-placement-agreement-130715-4621588/ 2015-07-13T09:24:00+00:00 https://www.pharmaceutical-business-review.com/news/eyegate-signs-licensing-deal-with-valeant-for-egp-437-combination-product-in-uveitis-130715-4621577/ 2015-07-13T09:26:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicomm-systems-signs-reseller-agreement-with-tri-i-biotech-shanghai-130715-4621585/ 2015-07-13T09:27:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-launches-taptiqom-preservative-free-fixed-combination-eye-drops-in-uk-130715-4621576/ 2015-07-13T09:30:00+00:00 https://www.pharmaceutical-business-review.com/news/turnstone-biologics-announces-enrollment-in-landmark-oncolytic-vaccine-trial-130715-4621580/ 2015-07-13T09:33:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-gets-fda-approval-for-lung-cancer-drug-iressa-140715-4621843/ 2015-07-14T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/five-prime-begins-phase-iii-trial-of-fpa008-to-treat-pigmented-villonodular-synovitis-140715-4621974/ 2015-07-14T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/corbus-begins-dosing-in-phase-ii-trial-of-resunab-to-treat-dermatomyositis-140715-4622032/ 2015-07-14T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-starts-phase-i-trial-of-cancer-combination-drug-140715-4622083/ 2015-07-14T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-reports-positive-phase-ii-trial-results-of-cancer-immunotherapy-atezolizumab-140715-4622115/ 2015-07-14T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/blueprint-medicines-gets-fda-nod-to-begin-clinical-trials-for-two-drug-candidates-140715-4622143/ 2015-07-14T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/aequus-enters-into-definitive-agreement-to-acquire-teora-health-140715-4622618/ 2015-07-14T09:14:00+00:00 https://www.pharmaceutical-business-review.com/news/psivida-reports-positive-top-line-results-from-phase-ii-trial-of-medidur-for-uveitis-140715-4622612/ 2015-07-14T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-acquires-22-generic-drug-products-from-teva-for-25m-140715-4622603/ 2015-07-14T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/first-glaucoma-patients-treated-in-netherlands-using-innfocus-microshunt-140715-4622600/ 2015-07-14T09:21:00+00:00 https://www.pharmaceutical-business-review.com/news/ohr-pharmaceutical-reports-positive-results-from-phase-ii-trial-of-ohr-102-in-retinal-vein-occlusion-140715-4622606/ 2015-07-14T09:23:00+00:00 https://www.pharmaceutical-business-review.com/news/cleave-biosciences-gets-fda-orphan-status-for-cb-5083-to-treat-multiple-myeloma-140715-4621932/ 2015-07-14T09:39:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-nda-to-fda-for-multiple-myeloma-drug-ixazomib-150715-4622862/ 2015-07-15T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-francis-crick-partner-to-explore-new-scientific-discoveries-150715-4622931/ 2015-07-15T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/npi-to-market-creative-medical-healths-bionutraceutical-products-150715-4623376/ 2015-07-15T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-memantine-hydrochloride-tablets-in-us-to-treat-dementia-150715-4623402/ 2015-07-15T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-egrifta-gets-approval-in-mexico-to-treat-lipodystrophy-150715-4623467/ 2015-07-15T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/beigene-begins-dosing-in-phase-ib-trial-of-bgb-283-to-treat-solid-tumors-150715-4623499/ 2015-07-15T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/newrons-sarizotan-gets-fda-orphan-status-to-treat-rett-syndrome-150715-4623582/ 2015-07-15T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/viking-therapeutics-submits-ind-application-for-vk5211-in-acute-hip-fracture-150715-4623700/ 2015-07-15T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/enteris-biopharma-oral-formulation-progresses-into-phase-ii-trial-with-cara-therapeutics-cr845-150715-4623694/ 2015-07-15T08:59:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-notice-of-allowance-for-patent-using-tb4-for-improving-neurological-outcomes-after-injury-and-neurodegenerative-disease-150715-4623716/ 2015-07-15T09:01:00+00:00 https://www.pharmaceutical-business-review.com/news/scioderm-to-submit-rolling-nda-to-fda-for-zorblisa-150715-4623703/ 2015-07-15T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/blaze-bioscience-announces-open-enrollment-for-phase-i-trial-of-tumor-paint-blz-100-150715-4623709/ 2015-07-15T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-musc-to-explore-new-treatments-for-fibrotic-diseases-160715-4624010/ 2015-07-16T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-enters-into-licensing-agreement-with-laboratorios-saval-for-zorvolex-160715-4624052/ 2015-07-16T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/canbridge-to-develop-and-commercialize-apogenixs-apg101-in-glioblastoma-for-china-160715-4624349/ 2015-07-16T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-status-for-immunovaccines-dpx-survivac-to-treat-ovarian-cancer-160715-4624366/ 2015-07-16T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenics-begins-enrollment-in-phase-ii-trial-of-targt-epo-to-treat-anemia-in-esrd-patients-160715-4624406/ 2015-07-16T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/merz-pharma-gets-health-canada-approval-for-radiesse-with-integral-03-lidocaine-160715-4624379/ 2015-07-16T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-gets-patent-in-japan-for-new-targeted-cancer-drug-delivery-platform-160715-4624387/ 2015-07-16T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-submits-orphan-drug-application-to-fda-for-rpi-78m-to-treat-multiple-sclerosis-160715-4624447/ 2015-07-16T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-agrees-to-acquire-receptos-for-72bn-160715-4624644/ 2015-07-16T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/five-prime-therapeutics-enters-into-research-collaboration-license-agreement-with-inhibrx-for-new-gitr-antibodies-160715-4624399/ 2015-07-16T09:14:00+00:00 https://www.pharmaceutical-business-review.com/news/premama-expands-with-two-new-pill-free-supplement-solutions-for-expecting-and-new-moms-160715-4624404/ 2015-07-16T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/argos-completes-patient-enrollment-in-phase-iii-adapt-trial-of-ags-003-160715-4624394/ 2015-07-16T09:21:00+00:00 https://www.pharmaceutical-business-review.com/news/panther-closes-acquisition-of-technology-assets-of-faulk-pharmaceuticals-170715-4625733/ 2015-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ocata-gets-new-us-patent-for-rpe-therapy-for-macular-degenerative-diseases-170715-4625753/ 2015-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/achaogen-gets-45m-niaid-contract-to-develop-new-lpxc-inhibitors-to-treat-bacterial-infections-170715-4625758/ 2015-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-kyowa-hakko-to-commercialize-benralizumab-in-japan-for-asthma-and-copd-170715-4625040/ 2015-07-17T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-evotaz-gets-european-approval-to-treat-hiv-1-infection-170715-4625123/ 2015-07-17T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-phase-ii-trial-results-of-blincyto-in-patients-with-ph-b-cell-precursor-all-170715-4625208/ 2015-07-17T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-galdermas-antibiotic-free-epiduo-forte-gel-to-treat-acne-patients-170715-4625428/ 2015-07-17T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-agrees-to-transfer-north-carolina-manufacturing-facility-to-biogen-170715-4625491/ 2015-07-17T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-gets-fda-nod-to-launch-generic-bivalirudin-for-injection-in-us-170715-4625551/ 2015-07-17T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/novogen-gets-fda-orphan-drug-status-for-anisina-to-treat-neuroblastoma-170715-4625594/ 2015-07-17T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/nanthealth-acquires-harris-healthcare-solutions-170715-4625741/ 2015-07-17T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/estroven-launches-new-two-in-one-intimacy-kit-for-women-170715-4625749/ 2015-07-17T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-divests-non-us-rights-of-entocort-to-tillotts-pharma-for-215m-200715-4626066/ 2015-07-20T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-and-c2ns-humanized-anti-tau-antibody-gets-fda-orphan-drug-status-to-treat-progressive-supranuclear-palsy-200715-4626111/ 2015-07-20T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-buy-amoun-pharmaceutical-for-800m-200715-4626640/ 2015-07-20T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-gets-approval-in-korea-for-phase-iibiii-trial-of-rgn-259-in-patients-with-des-200715-4626657/ 2015-07-20T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-gets-fda-approval-for-dysport-for-injection-to-treat-upper-limb-spasticity-in-adults-200715-4626691/ 2015-07-20T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-launches-saphris-25-mg-sublingual-tablets-in-us-200715-4626736/ 2015-07-20T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/motifs-iclaprim-gets-fda-qidp-designation-for-habp-200715-4626786/ 2015-07-20T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cellecta-receives-nih-sbir-grant-to-develop-validated-crispr-knockout-library-of-guide-rna-sgrna-sequences-200715-4626689/ 2015-07-20T09:25:00+00:00 https://www.pharmaceutical-business-review.com/news/aquinnah-pharma-gets-05m-frants-from-als-association-200715-4626700/ 2015-07-20T09:26:00+00:00 https://www.pharmaceutical-business-review.com/news/contrafect-gets-key-patent-from-uspto-covering-new-lysin-technology-200715-4626708/ 2015-07-20T09:28:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-to-present-successful-phase-iii-trial-results-for-new-celiac-treatment-at-international-celiac-disease-symposium-200715-4626696/ 2015-07-20T09:30:00+00:00 https://www.pharmaceutical-business-review.com/news/recro-pharma-reports-positive-top-line-results-for-phase-ii-trial-of-dex-in-200715-4626704/ 2015-07-20T09:32:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-begins-phase-iii-apollo-ole-trial-of-patisiran-to-treat-attr-amyloidosis-210715-4627125/ 2015-07-21T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-gets-approval-in-europe-to-extend-kuvan-use-for-children-with-pku-210715-4627244/ 2015-07-21T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myerss-phase-iii-rcc-trial-of-opdivo-shows-superior-overall-survival-over-everolimus-210715-4627275/ 2015-07-21T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/erytech-reports-positive-results-from-phase-ii-trial-of-ery-asp-in-pancreatic-cancer-patients-210715-4627646/ 2015-07-21T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/delcath-gets-fda-orphan-drug-status-for-melphalan-to-treat-cholangiocarcinoma-210715-4627686/ 2015-07-21T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/stemcells-treats-first-patient-in-phase-ii-hucns-sc-trial-for-dry-amd-210715-4627744/ 2015-07-21T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/asahi-kasei-gets-approval-for-xiaflex-in-japan-to-treat-dupuytrens-contracture-210715-4627797/ 2015-07-21T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-jcr-to-discover-new-cns-treatments-using-bbb-penetration-technology-220715-4628122/ 2015-07-22T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/forge-enters-into-pilot-study-with-janssen-to-discover-new-metalloprotein-inhibitors-220715-4628481/ 2015-07-22T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/mgb-biopharma-begins-phase-i-trial-of-oral-mgb-bp-3-to-treat-clostridium-difficile-infections-220715-4628461/ 2015-07-22T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharmaceuticals-begins-phase-iiia-trial-of-isis-htt-to-treat-patients-with-huntingtons-disease-220715-4628519/ 2015-07-22T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cerulean-doses-first-patient-in-phase-ib-trial-of-crlx101-paclitaxel-combination-in-relapsed-ovarian-cancer-220715-4628536/ 2015-07-22T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-gets-fda-breakthrough-therapy-status-for-investigational-hiv-1-attachment-inhibitor-220715-4628571/ 2015-07-22T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/knight-therapeutics-gets-exclusive-distribution-rights-of-alimeras-iluvien-in-canada-to-treat-dme-220715-4628599/ 2015-07-22T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/spero-achieves-first-milestone-payment-in-anti-infective-partnership-with-roche-220715-4628968/ 2015-07-22T09:16:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-reports-additional-phase-iia-data-for-bms-955176-to-prevent-maturation-of-hiv-1-220715-4628955/ 2015-07-22T09:18:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-amgens-repatha-to-treat-high-cholesterol-220715-4628960/ 2015-07-22T09:20:00+00:00 https://www.pharmaceutical-business-review.com/news/simulations-plus-extends-research-deal-with-niehs-220715-4628959/ 2015-07-22T09:23:00+00:00 https://www.pharmaceutical-business-review.com/news/lysogene-alcyone-lifesciences-enter-collaboration-for-mucopolysaccharidosis-type-iiia-220715-4628963/ 2015-07-22T09:24:00+00:00 https://www.pharmaceutical-business-review.com/news/genmabs-partner-novartis-submits-sbla-to-fda-for-ofatumumab-to-treat-relapsed-cll-230715-4629213/ 2015-07-23T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-challenge-novartis-in-axial-spondyloarthrtis-treatment-space-says-globaldata-230715-4629407/ 2015-07-23T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-agrees-to-buy-german-dietary-supplement-brand-yokebe-230715-4629372/ 2015-07-23T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-sheffield-university-to-research-in-cell-factory-technology-230715-4629337/ 2015-07-23T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-expands-lease-agreement-with-kendall-square-for-research-facility-230715-4629252/ 2015-07-23T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-gets-european-commission-approval-to-treat-advanced-melanoma-230715-4629607/ 2015-07-23T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-expands-immuno-oncology-collaboration-with-merck-230715-4629655/ 2015-07-23T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-reports-positive-results-from-phase-i-ebola-gp-vaccine-trial-230715-4629712/ 2015-07-23T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-gets-notice-of-acceptance-for-australian-patent-for-key-tb4-peptide-fragment-230715-4630064/ 2015-07-23T09:07:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiome-submits-supplemental-new-drug-submission-for-aggrastat-to-health-canada-230715-4630073/ 2015-07-23T09:11:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-awarded-grant-to-study-arcus-technology-in-respiratory-distress-syndrome-230715-4630079/ 2015-07-23T09:16:00+00:00 https://www.pharmaceutical-business-review.com/news/tract-therapeutics-completes-phase-i-safety-trial-using-patients-immune-cells-to-prevent-organ-rejection-230715-4630086/ 2015-07-23T09:23:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-theravances-vibativ-for-hapvap-caused-by-gram-positive-bacteria-240715-4630325/ 2015-07-24T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-submits-snda-to-fda-for-kyprolis-to-treat-relapsed-multiple-myeloma-240715-4630468/ 2015-07-24T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-bristol-myerss-two-type-ii-variation-applications-to-extend-opdivo-indication-240715-4630476/ 2015-07-24T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/lpath-gets-fda-nod-to-initiate-phase-i-lpathomab-clinical-trial-240715-4630379/ 2015-07-24T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-snda-for-olysio-in-combination-with-sofosbuvir-to-treat-chc-infection-240715-4630487/ 2015-07-24T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/tty-biopharm-to-market-pharmamars-aplidin-in-taiwan-to-treat-hematological-cancers-240715-4630620/ 2015-07-24T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/heron-begins-second-phase-ii-trial-of-htx-011-to-treat-post-operative-pain-240715-4630735/ 2015-07-24T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-mercks-maa-for-grazoprevirelbasvir-to-treat-chronic-hepatitis-c-infection-240715-4631058/ 2015-07-24T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-extends-collaboration-with-biomed-x-240715-4631064/ 2015-07-24T09:23:00+00:00 https://www.pharmaceutical-business-review.com/news/pulmatrix-issued-patents-covering-isperse-technology-to-treat-patients-with-inhaled-dry-powders-240715-4631065/ 2015-07-24T09:27:00+00:00 https://www.pharmaceutical-business-review.com/news/eagle-pharmaceuticals-rtu-bivalirudin-nda-accepted-for-filing-by-fda-240715-4631067/ 2015-07-24T09:32:00+00:00 https://www.pharmaceutical-business-review.com/news/national-pharma-industries-introduces-new-allergy-medication-naramin-240715-4631069/ 2015-07-24T09:40:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-gets-ema-committee-positive-opinion-for-malaria-candidate-vaccine-mosquirix-270715-4631181/ 2015-07-27T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-technivie-gets-fda-approval-to-treat-genotype-4-chronic-hepatitis-c-270715-4631208/ 2015-07-27T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-and-regenerons-praluent-gets-fda-approval-to-treat-high-ldl-cholesterol-in-adults-270715-4631772/ 2015-07-27T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/eddingpharm-to-begin-phase-i-trial-of-brinavess-in-china-270715-4631784/ 2015-07-27T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-skin-cancer-drug-odomzo-gets-fda-approval-270715-4632021/ 2015-07-27T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/knight-therapeutics-to-manage-regulatory-commercial-activities-for-azasite-in-canada-270715-4631993/ 2015-07-27T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-agrees-to-acquire-naurex-for-560m-270715-4632053/ 2015-07-27T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-gets-ema-committee-positive-opinion-for-intuniv-to-treat-adhd-270715-4632067/ 2015-07-27T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/eyegate-gets-uspto-notice-of-allowance-for-proprietary-dexamethasone-phosphate-formulation-270715-4632072/ 2015-07-27T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-gets-fda-orphan-drug-status-for-ad-rts-hil-12-to-treat-malignant-glioma-270715-4632079/ 2015-07-27T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-amgens-kyprolis-for-combination-use-to-treat-relapsed-multiple-myeloma-270715-4632091/ 2015-07-27T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-parenteral-medicines-begins-recall-of-select-lots-of-adrucil-5g100ml-due-to-particulate-matter-270715-4632099/ 2015-07-27T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-gets-ema-committee-positive-opinion-for-investigational-antibiotic-zerbaxa-280715-4633261/ 2015-07-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-agrees-to-buy-allergan-generics-for-405bn-280715-4632367/ 2015-07-28T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/bloomage-medytox-set-up-new-jv-to-jointly-develop-botulinum-toxin-market-in-china-280715-4632665/ 2015-07-28T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/invion-hovione-sign-joint-development-and-licensing-deal-for-inhaled-zafirlukast-280715-4632669/ 2015-07-28T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/monosol-rx-begins-phase-iia-trial-for-oral-insulin-film-280715-4632675/ 2015-07-28T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-launches-glucagon-for-injection-in-us-280715-4632680/ 2015-07-28T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/adapt-pharma-submits-nda-to-fda-for-narcan-nasal-spray-280715-4632691/ 2015-07-28T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-begins-phase-i-trial-of-ino-5150-dna-immunotherapy-to-treat-prostate-cancer-280715-4632867/ 2015-07-28T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxin-enrolls-first-patient-in-phase-i-trial-of-heptcell-to-treat-hepatitis-b-virus-280715-4632896/ 2015-07-28T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/chinas-yabao-and-lawson-complete-discovery-validation-work-of-annexin-a5-based-products-280715-4632909/ 2015-07-28T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dndi-takeda-to-develop-new-treatment-for-visceral-leishmaniasis-280715-4632974/ 2015-07-28T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-genzyme-agrees-to-buy-astrazenecas-rare-disease-therapy-caprelsa-for-300m-280715-4633294/ 2015-07-28T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-sprint-bioscience-partner-to-develop-new-oncology-drug-candidates-290715-4633581/ 2015-07-29T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-enters-strategic-alliance-to-develop-new-parkinsons-disease-treatments-290715-4633633/ 2015-07-29T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-hanmi-to-develop-third-generation-egfr-targeted-therapy-in-lung-cancer-290715-4633706/ 2015-07-29T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-ends-otc-lipitor-program-after-trial-fails-290715-4633928/ 2015-07-29T05:31:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/chpa-welcomes-house-introduction-of-dxm-abuse-prevention-act-290715-4634128/ 2015-07-29T06:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/protecting-access-to-pain-relief-coalition-launches-toensure-americans-have-access-to-trusted-pain-relief-290715-4634140/ 2015-07-29T06:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/donaldson-and-business-review-free-webinar-series-offers-specialized-content-for-pharmahealthcarepackaging-food-and-beverage-industry-professionals-4634275/ 2015-07-29T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-begins-phase-i-trial-of-anti-rspo3-antibody-290715-4634321/ 2015-07-29T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-status-for-progenics-azedra-to-treat-pheochromocytoma-and-paraganglioma-290715-4634347/ 2015-07-29T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-confirms-successful-validation-of-tevas-reslizumab-maa-290715-4634375/ 2015-07-29T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-sanofi-launch-new-immuno-oncology-collaboration-290715-4634448/ 2015-07-29T09:12:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-improves-immuno-oncology-portfolio-with-acquisition-of-ccam-biotherapeutics-290715-4634451/ 2015-07-29T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-opkos-nda-for-rayaldee-to-treat-ckd-290715-4634456/ 2015-07-29T09:27:00+00:00 https://www.pharmaceutical-business-review.com/news/highland-subsidiary-ironshore-begins-phase-iii-trial-of-hld-200-in-pediatric-adhd-patients-300715-4635225/ 2015-07-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eisais-lenvima-gets-fda-breakthrough-status-for-renal-cell-carcinoma-300715-4634643/ 2015-07-30T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-zs-pharmas-zs-9-nda-to-treat-hyperkalemia-300715-4634684/ 2015-07-30T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-agrees-to-acquires-roxane-laboratories-for-118bn-300715-4634957/ 2015-07-30T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-begins-phase-ii-trial-of-apd334-to-treat-autoimmune-diseases-300715-4634963/ 2015-07-30T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/cssi-lifesciences-prc-clinical-partner-to-provide-extended-clinical-trial-services-300715-4634973/ 2015-07-30T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/lightlake-partner-adapt-pharma-submits-nda-to-fda-for-narcan-nasal-spray-300715-4634980/ 2015-07-30T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-first-lixilan-phase-iii-trial-meets-primary-endpoint-300715-4634986/ 2015-07-30T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-bristol-myers-enter-into-immuno-oncology-clinical-collaboration-300715-4635082/ 2015-07-30T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/flexion-completes-patient-enrollment-in-fx006-phase-iii-trial-for-osteoarthritis-of-the-knee-300715-4635183/ 2015-07-30T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/kalobios-gets-fda-clearance-for-ind-application-for-kb003-to-treat-patients-with-cmml-300715-4635203/ 2015-07-30T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-begins-phase-i-trial-of-al-704-to-treat-hepatitis-c-300715-4635252/ 2015-07-30T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-deltoid-injection-site-for-abilify-maintena-for-extended-release-injectable-suspension-to-treat-schizophrenia-310715-4636503/ 2015-07-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-confirms-generic-tyvaso-patent-challenge-310715-4636508/ 2015-07-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genkyotexs-nox14-inhibitor-strategy-in-liver-fibrosis-supported-by-new-preclinical-results-310715-4636511/ 2015-07-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-reports-topline-results-from-phase-iii-active-trial-of-isavuconazole-in-patients-with-candidemia-310715-4636514/ 2015-07-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/unichem-issues-voluntary-nationwide-recall-of-hydrochlorothiazide-tablets-310715-4636516/ 2015-07-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-and-halozyme-to-evaluate-combination-drug-for-treatment-of-metastatic-breast-cancer-310715-4635809/ 2015-07-31T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-licenses-captisol-to-sanofi-for-development-of-met-kinase-inhibitor-310715-4635925/ 2015-07-31T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-humira-gets-european-approval-to-treat-hidradenitis-suppurativa-310715-4635952/ 2015-07-31T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pediatric-cancer-treatment-based-on-nanosmart-platform-obtains-fdas-orphan-drug-status-310715-4636000/ 2015-07-31T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/juno-ind-application-given-fda-nod-for-leukemia-drug-candidate-jcar015-310715-4635987/ 2015-07-31T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ferrer-completes-second-phase-iii-trial-of-impetigo-treatment-ozenoxacin-310715-4636034/ 2015-07-31T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/neos-resubmits-adhd-drug-application-for-fda-review-310715-4636100/ 2015-07-31T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-genetics-reports-positive-interim-data-from-vsv-zebov-ebola-vaccine-candidate-trial-030815-4637721/ 2015-08-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bmg-pharma-signs-distribution-agreement-with-sayre-therapeutics-030815-4637722/ 2015-08-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-receives-uspto-additional-notice-of-allowance-for-pennsaid-2-030815-4637723/ 2015-08-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-reports-positive-data-from-phase-iii-ring-vaccination-trial-of-ebola-vaccine-rvsv-zebov-030815-4637726/ 2015-08-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-finacea-gets-fda-approval-to-treat-papulopustular-rosacea-030815-4636788/ 2015-08-03T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/japans-mhlw-approves-patient-enrollment-in-adresu-trial-for-stress-urinary-incontinence-030815-4637257/ 2015-08-03T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/synergy-reports-positive-phase-iii-trial-results-of-plecanatide-in-cic-patients-030815-4637287/ 2015-08-03T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-perjeta-gets-european-approval-for-neoadjuvant-treatment-of-her2-positive-ebc-030815-4637333/ 2015-08-03T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-reports-positive-phase-ii-trial-results-of-quadrivalent-seasonal-influenza-vlp-vaccine-030815-4637358/ 2015-08-03T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/adma-submits-ri-002-biologics-license-application-to-fda-030815-4637516/ 2015-08-03T08:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-mundipharmas-ind-for-edo-s101-to-treat-haematologic-malignancies-030815-4637584/ 2015-08-03T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-to-buy-foresight-biotherapeutics-for-300m-040815-4637751/ 2015-08-04T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-acquire-us-commercializatoin-rights-of-synthons-glatiramer-acetate-to-treat-rrms-040815-4638131/ 2015-08-04T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/charleston-begins-phase-i-trial-of-migraine-drug-candidate-cl-h1t-040815-4638114/ 2015-08-04T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/aprecias-first-3d-printed-drug-product-spritam-gets-fda-approval-to-treat-epilepsy-040815-4638083/ 2015-08-04T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-isis-partner-to-discover-and-develop-new-antisense-drugs-040815-4638098/ 2015-08-04T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/beigene-gets-cfda-approval-to-begin-clinical-trials-with-bgb-283-to-treat-solid-tumors-040815-4638178/ 2015-08-04T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-to-acquire-51-stake-in-genomic-analysis-firm-immuneering-040815-4638162/ 2015-08-04T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/codexis-signs-codeevolver-platform-technology-license-agreement-with-merck-040815-4638795/ 2015-08-04T09:51:00+00:00 https://www.pharmaceutical-business-review.com/news/contravir-enrolls-first-patient-in-phase-iii-trial-fv-100-to-treat-shingles-and-shingles-associated-pain-040815-4638796/ 2015-08-04T09:57:00+00:00 https://www.pharmaceutical-business-review.com/news/cidara-begins-phase-i-trial-of-lead-antifungal-product-candidate-cd101-iv-040815-4638798/ 2015-08-04T10:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ihs-completes-acquisition-of-iba-molecular-north-america-040815-4638800/ 2015-08-04T10:03:00+00:00